Mammary Apoptosis by Quarrie, Lynda H
MAMMARY APOPTOSIS
LYNDA H. QUARRIE
A thesis submitted to the University of Glasgow in accordance with 
requirements for the degree of Doctor of Philosophy in the Faculty of 
Science.
Hannah Research Institute, Ayr March 1996.
ProQuest Number: 13833378
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13833378
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
CONTENTS
page
Contents 1
List of Figures V
List of Tables VIII
List of Abbreviations IX
Acknowledgments X
Publications XI
Declaration XII
Abstract XIII
Chapter one: Review of the literature
1.1 Discovery of apoptotic cell death 1
1.2 Types of cell death 2
1.2.1 Characteristics of programmed cell death 2
1.2.2 Characteristics of necrosis 2
1.2.3 Characteristics of apoptosis 3
1.3 Regulation of apoptosis 5
1.4 Mechanism of apoptosis 6
1.4.1 Regulatory role of bcl-2 in apoptosis 6
1.4.2 Regulatory role of p53, tumour suppressor oncogene in 8 
apoptosis
1.5 Biological importance of apoptosis 10
1.5.1 Apoptosis during fetal life 10
1.5.2 Apoptosis regulates tissue mass 11
1.5.3 Apoptosis regulating disease progression 11
1.5.4 Apoptosis in tissue involution 12
1.6 Apoptosis in mammary tissue 12
1.7 The purpose of mammary development 13
1.7.1 Domestic and laboratory species 13
1.8 The pattern of mammary development 14
1.8.1 The lactation cycle 15
1.9 Phases of mammary development 15
1.9.1 Mammary development during gestation 15
1.9.2 Mammary development during lactation 17
1.9.2.1 Mice 17
1.9.2.2 Rats 17
1.9.2.3 Goats 18
I
1.9.3 Mammary cell loss during involution 18
1.10 Control of mammary development 19
1.10.1 Control of mammary development during gestation 19
1.10.2 Control of mammary development in lactation 20
1.10.3 Co-ordination of mammary involution 22
1.11 Basement membrane control of mammary function 23
1.12 Apoptosis during mammary involution 24
1.12.1 Initial identification of mammary apoptosis 24
1.12.2 Characterisation of mammary gene expression 25 
associated with apoptosis
1.13 Aims of this study 26
Chapter two: Materials and methods
2.1 Materials 30
2.1.1 Chemicals 30
2.1.2 Animals 30
2.2 Experimental procedures 31
2.2.1 Mice experiments 31
2.2.2 Rat experiments 32
2.2.3 Goat experiments 32
2.3 Cell culture 33
2.3.1 Cell culture media 33
2.3.2 Preparation of mammary cells - 34
2.4 DNA studies 36
2.4.1 Extraction of DNA 36
2.4.2 DNA electrophoresis 37
2.4.3 End labelling of DNA 37
2.4.4 DNA assay 37
2.5 Histology 38
2.5.1 Tissue collection 38
2.5.2 Histological analysis 38
2.5.3 In situ end labelling of DNA 40
2.6 RNA studies 40
2.6.1 RNA extraction 40
2.6.2 RNA electrophoresis 41
2.6.3 Preparation of cDNA probes 41
II
2.6.4 Northern blotting with cDNA probes 43
2.6.5 Design of oligonucleotides 44
2.6.6 Northern blotting with oligonucleotide probes 44
2.7 Densitometry 45
Chapter three: Apoptosis in mouse mammary tissue
3.1 Introduction 47
3.2 Experimental protocol 48
3.2.1 Litter removal 48
3.2.2 Natural weaning 48
3.2.3 Natural weaning in concurrently pregnant mice 48
3.2.4 Milk stasis 49
3.3 Results 49
3.3.1 Litter removal at mid-lactation 49
3.3.2 Litter removal during declining lactation 50
3.3.3 Natural weaning 53
3.3.4 Milk stasis 56
3.4 Discussion 57
Chapter four: Hormonal regulation of apoptosis
4.1 Introduction 63
4.2 Experimental protocol - 64
4.3 Results 65
4.3.1 Lactating tissue 65
4.3.2 Litter removal 65
4.3.3 Hormone neutralisation 66
4.3.4 Hormone replacement 67
4.4 Discussion 67
Chapter five: Apoptosis in ruminant lactation
5.1 Introduction 72
5.2 Experimental protocol 73
5.2.1 Unilateral milk stasis 73
5.2.2 Unilateral manipulation of milking frequency 73
III
5.3 Results 74
5.3.1 Unilateral milk stasis 74
5.3.2 Effect of unilateral alteration of milking frequency 74
5.3.3 Goat mammary gene expression 75
5.4 Discussion 75
Chapter six: Mechanism of mammary apoptosis
6.1 Introduction 79
6.2 Experimental protocol 80
6.3 Results 81
6.4 Discussion 83
Chapter seven: Summary and discussion 89
Bibliography 96
I
IV
LIST OF FIGURES
Chapter three
Fig. 3.1 Histology of mouse mammary tissue after litter removal in 
mid-lactation.
Fig. 3.2 DNA laddering in mouse mammary tissue after litter removal 
in mid-lactation.
Fig. 3.3 DNA laddering in mouse mammary tissue at mid-lactation.
Fig. 3.4 Histology of mouse mammary tissue after litter removal in 
declining lactation.
Fig. 3.5 DNA laddering in mouse mammary tissue after litter removal 
in declining lactation.
Fig. 3.6 Optimisation of nick end-labelling for visualisation of DNA 
ladders in mouse mammary tissue.
Fig. 3.7 In situ end-labelling (ISEL) of mouse mammary tissue sections 
with biotinylated dUTP.
Fig. 3.8 In situ end-labelling (ISEL) of mouse mammary tissue sections.
Fig. 3.9 Mouse mammary gene expression after litter removal on day 
10 of lactation.
Fig. 3.10 Mouse mammary gene expression after litter removal on day 
16 of lactation.
Fig. 3.11 Comparison of mammary gene expression after litter removal 
on day 16 and day 10 of lactation.
Fig 3.12 Histology of mouse mammary tissue during natural weaning.
Fig. 3.13 DNA laddering in mouse mammary tissue during natural 
weaning.
Fig. 3.14 Mouse mammary gene expression during natural weaning.
Fig. 3.15 Comparison of mouse mammary gene expression during 
natural weaning and after litter removal.
V
Fig. 3.16 Histology of mouse mammary tissue during natural weaning in 
non-pregnant and pregnant mice.
Fig. 3.17 DNA laddering during natural weaning in concurrently 
pregnant mice.
Fig. 3.18 Mammary gene expression during weaning in concurrently 
pregnant mice.
Fig. 3.19 Comparison of mouse mammary gene expression during 
natural weaning in non-pregnant and prgnant mice.
Fig. 3.20 Macroscopic appearance of mouse mammary tissue after 
unilateral teat sealing.
Fig. 3.21 Histology of mouse mammary tissue after unilateral teat 
sealing.
Fig. 3.22 DNA laddering after unilateral teat sealing of mouse mammary 
glands in mid-lactation.
Fig. 3.23 Comparison of gene expression induced by unilateral milk 
stasis at mid-lactation.
Chapter four
Fig. 4.1 Histology of rat mammary tissue.
Fig. 4.2 DNA laddering of rat mammary tissue.
Fig. 4.3 Evidence for early changes characteristic of apoptosis in rat 
mammary tissue.
Fig. 4.4 Nick end-labelling of rat mammary DNA.
Chapter five
Fig. 5.1 Histology of goat mammary gland after unilateral cessation of 
milking.
VI
Fig. 5.2 
Fig. 5.3 
Fig. 5.4 
Fig. 5.5
Chapter
Fig. 6.1
Fig. 6.2 
Fig. 6.3 
Fig. 6.4 
Fig. 6.5 
Fig. 6.6
Fig. 6.7
Fig. 6.8 
Fig. 6.9
Histology of goat mammary gland after unilateral cessation of 
milking.
DNA laddering induced by unilateral milking in declining 
lactation.
DNA laddering before and after unilateral alteration of milking 
frequency.
Histology of once and thrice daily milked glands.
six
Appearance of mouse mammary cell clumps plated on 
extracellular matrix.
Formation of lumina in mouse mammary cells.
Secretion of milk components by the mouse mammospheres.
Secretion of milk components by the mouse mammospheres.
Secretion of milk components by the mouse mammospheres.
DNA laddering in mouse mammary epithelial cells on EHS 
matrix.
Apoptotic bodies within the mouse mammary cell clumps at 
day 3 or 4 of culture.
Laminin staining of mouse cell clumps.
IGFBP levels in conditioned media from mouse mammary cells 
cultured on EHS.
VII
LIST OF TABLES
Table
Table
Table
2.1 Preparation of cDNA probes.
3.1 Quantitative analysis of DNA laddering in mouse mammary 
tissue.
5.1 Milk yield data after once and thrice daily milking.
VIII
LIST OF ABBREVIATIONS
AGS -anti growth hormone serum
Br -bromocriptine
DAB -diaminobenzidene
DAPI -diaminophenylindole
cortisol -hydrocortisone-21 -acetate
EHS -englebreth holm swarm
FIL -feedback inhibitor of lactation
GH -growth hormone
h -hour or hours
H + E -haematoxylin and eosin
IGF -insulin like growth factor
IGFBP -insulin like growth factor binding protein
IL -interleukin
ISEL -in situ end labelling
P -probability
RMYQ -relative milk yield quotient
SDS -sodium dodecyl sulphate
SEM -standard error of the mean
TIMP -tissue inhibitor of metalloproteinase
Tris -tris(hydroxymethyl)aminomethane
WAP -whey acidic protein
ABC -avidin biotin complex
|OCT Optimum cutting temperature
IX
ACKNOWLEDGMENTS
I wish firstly to thank Drs. Colin Wilde and Caroline Addey for supervising 
this project, and for giving me so much advice and encouragement throughout 
my three years at the Hannah Research Institute. I also wish to extend this 
"thank-you" to all members of the Director’s group for making my stay an 
enjoyable and memorable one. In particular, I would like to thank Dave 
Blatchford for firstly showing me the mouse mammary cell culture techniques 
and for helping me with so many of the culture experiments. I also wish to 
thank Dr. Peter Bird, who, as a visiting worker to the Director’s group, was 
so interested in my project and helped me develop the [32P] nick end labelling 
method for genomic DNA. In addition, I will not forget the help, enthusiasm 
and encouragement of Dr. Mike Barber, without whom my study of mouse 
mammary apoptosis would be nowhere near as comprehensive or as 
interesting.
As for the photography, I wish to thank both Derek Cooney of the Hannah 
Research Institute and Trevor Graham at the University of Glasgow. From 
outside the Institute I also wish to thank Dr. Bijan Ansari, who gave me 
valuable advice on ISEL cell staining techniques and to thank those I have not 
met who gave me cDNA probes for use in these studies.
X
LIST OF PUBLICATIONS
The results presented in his thesis have been published in part in the following 
journals.
Quarrie, L.H., Addey, C.V.P. & Wilde, C.J. (1994). Local regulation of 
mammary apoptosis in the lactating goat, Biochem. Soc. Trans., 22, 178S.
Quarrie, L.H., Addey, C.V.P. & Wilde, C.J. (1995). Local regulation of 
mammary apoptosis by milk stasis, In intracellular signalling in the mammary 
gland, (eds. Wilde, C.J., Peaker, M. & Knight, C.H.), 95-96, Plenum Press, 
London.
Quarrie, L.H., Addey, C.V.P. & Wilde, C.J. (1995). Apoptosis in lactating 
and involuting mouse mammary tissue demonstrated by nick-end DNA 
labelling, Cell Tissue Res., 281, 413-419.
Tonner, E., Quarrie, L.H., Travers, M., Logan, A., Beattie, J., Wilde, C.J. 
& Flint, D.J. (1995). Does IGF- binding protein (IGFBP) present in 
involuting rat mammary gland stimulate apoptosis? Proceedings o f the third 
international symposium on IGF binding proteins, Tuebingen, October, 1995.
Quarrie, L.H., Tonner, E., Blatchford, D.R., Flint, D.J. & Wilde, C.J. 
(1996). Regulation of apoptosis in cultured mammary epithelial cells, In 
Animal cell technology: basic and applied aspects, Vol 8, (ed. Matsushita, 
T.), Kluwer Press, Dordrecht, in press.
Travers, M.T., Barber, M.C., Tonner, E., Quarrie, L.H., Wilde, C.J. & 
Flint, D.J. (1996). The role of prolactin and growth hormone in the regulation 
of casein gene expression and mammary cell survival; relationship to milk 
synthesis and secretion, Endocrinology, in press.
Quarrie, L.H., Addey, C.V.P. & Wilde, C.J. (Programmed cell death during 
mammary tissue involution induced by weaning, litter removal and milk stasis, 
J. Cell Physiol., In revision.
XI
DECLARATION
All data were collected by myself, with the exceptions of animal 
experimentation performed by Dr. D.Flint and M. Gardiner in Chapter 4 and 
the IGFBP ligand blot and IGFBP Northern blot performed by E. Tonner and 
Dr. M. Travers, respectively in Chapter 6. With these exceptions, I declare 
that the work contained in this thesis is my own, undertaken under the 
supervision and guidance of Dr. C.J. Wilde and Dr. C.V.P. Addey. No part 
of this work has been submitted for consideration for any other degree or 
award.
Lynda H. Quarrie.
ABSTRACT
This thesis examines the importance of mammary apoptosis during lactation and 
involution and investigates some of the factors which influence apoptotic rates in the 
mammary gland.
The extent of apoptosis in mammary tissue was assessed using [32P] dCTP 
nick-end labelled DNA to visualise DNA laddering. Changes in DNA laddering were 
compared with histological techniques to determine general tissue morphology, 
chromatin changes and presence of apoptotic bodies and localisation of dying cells 
(ISEL). Where possible these measurements were combined with gene expression 
studies to determine changes in expression of proteases, inhibitors of proteases, p53 
and bax.
As shown previously, apoptosis is important for cell removal in rodents during 
natural weaning and after litter removal at peak lactation. In both situations apoptosis 
followed a similar timecourse, however, after litter removal in declining lactation the 
increase in apoptosis was more rapid. Apoptosis also appeared to be essential between 
lactation cycles even when the interval between lactation cycles was reduced to a 
minimum by mating at post partum oestrus. DNA laddering was detected at peak 
lactation of mice, rats and goats, suggesting that cell turnover is a physiological process 
in lactating tissue.
This study also investigated the regulation of mammary apoptosis. The effects 
of hormonal status of lactating rats and milk stasis in mice and goats were investigated. 
Prolactin, acting as a cell survival factor, was shown to influence apoptosis. Growth 
hormone action was more subtle, and was achieved through a different mechanism to
that of prolactin. A local mechanism for regulating mammary apoptosis was 
demonstrated in mice where unilateral milk stasis induced apoptosis at levels similar 
to litter removal. Apoptosis was also induced in goats by a local control mechanism 
since unilateral cessation of milking increased apoptosis to a greater degree in unmilked 
glands compared to milked glands.
Finally, possible mechanisms of local and systemic control were studied during 
lumen formation when mammary cells were cultured on extracellular matrix, in vitro. 
After several days on extracellular matrix solid clumps of epithelial cells form hollow 
spherical structures. Cells on the periphery of the cell clump survive, and only these 
have access to laminin, (a component of the extracellular matrix). Cells in the centre 
of the clumps die by apoptosis, and this produces luminal spaces within the structures. 
An IGFBP is also elevated at the time of apoptotic cell removal, and may be involved 
in blocking IGF-1 activity in cells that are to die.
In conclusion, this study demonstrates the widespread importance of apoptosis 
in the mammary gland, the local and systemic regulation of the process and some clues 
as to the mechanism of apoptosis in mammary cells.
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CHAPTER ONE 
REVIEW OF THE LITERATURE
1.1 Discovery of apoptotic cell death
A new and orderly sequence of events during cell death was described by Kerr (1965), 
while investigating histochemical changes during hepatic ischaemia in the rat. It was 
discovered that during parenchymal regression, individual hepatocytes underwent a 
series of histological changes which differed from those of necrotic cells (Kerr, 1965). 
The hepatocytes were continually converted into small round cytoplasmic masses, some 
of which contained fragments of pycnotic chromatin. The lysosomes in these small 
round masses stained discretely, suggesting they were intact. Importantly, apparently 
identical rounded cytoplasmic masses were detected in small numbers in the livers of 
healthy rats. This process was referred to initially as "shrinkage necrosis" (Kerr, 
1971). However the use of the term necrosis for a phenomenon that occurred under 
physiological conditions seemed undesirable, so the process was renamed apoptosis (a 
Greek word used to describe the shedding of leaves from a tree or petals from flowers; 
Kerr et al., 1972).
The same sequence of apoptotic events has been detected in a great variety of 
animal tissues. An apparently similar process, at least as far as nuclear changes are 
concerned, occurs in normal plants (Eleftheriou, 1986). This suggests that apoptosis 
is a process which originated early in biological evolution.
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1.2 Types of cell death
1.2.1 Characteristics of programmed cell death
The morphological changes observed in cells undergoing programmed cell death 
include controlled condensation of the cell, shrinkage of cytoplasm, condensation of 
chromatin and absence of inflammatory reaction. This showed this type of cell death 
resembled apoptosis more than necrosis. Presently, programmed cell death is 
considered to be an apoptotic type of cell death. Death is referred to as programmed 
or apoptotic depending upon whether the death is planned in a developmental sequence 
(programmed cell death) or is a potential solution to an inadvertant but dangerous 
situation (apoptosis). However, there is considerable overlap between the two 
processes and it is often not clear if death is apoptotic or programmed. Therefore the 
two terms are often interchangable.
1.2.2 Characteristics of necrosis
Events during necrotic cell death have been reviewed by Walker et al. (1988). Until 
the 1980’s cell death was regarded solely as a necrotic process, i.e. a relatively 
uncontrolled progressive degradation of cell structure that occurs after death, caused 
by severe injurious changes in environmental conditions. For example, necrotic death 
occurred after exposure to hyperthermia, hypoxia, ischemia, complement attack or 
metabolic poisons (Schanne et al., 1979; Trump et al., 1981; Laiho et al., 1983).
Necrotic cells often loose specialised surface structures such as microvilli and 
develop surface blebs (Ginn et al., 1969), and also show mild swelling of mitocondria 
and cytoplasm, dilation of endoplasmic reticulum (ER), depletion of glycogen, 
dissociation of ribosomes, dispersal of polysomes and irregular clumping of chromatin
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around the nuclear membrane. The plasma, organelle and nuclear membranes become 
more permeable, and fluid moves more freely across these membranes causing cells to 
swell. Further mitochondrial swelling occurs. Mitochondria now appear flocculent or 
contain densely granular matrix. Such an appearance is regarded as being the earliest 
reliable ultrastructural marker of necrosis (Jennings and Reimer, 1981). Lysosomal 
enzymes are released, resulting in destruction of cell organelles, chromatin disappears 
to leave ghost nuclei (karyolysis) and the cells membranes are no longer intact 
(Hawkins et al., 1972; Kloner et al., 1974). Breakdown in cellular components is 
coincident with the release of free fatty acids, free amino acids and inorganic 
phosphates from the necrotic cells (Trump et al., 1981; 1984). DNA exposed by 
proteolytic digestion of histones, is cleaved by lysosomal deoxyribonuclease into 
fragments displaying a continuous spectrum of sizes (Afanasev et al., 1986; Duvall and 
Wyllie, 1986).
Typically, groups of contiguous cells are affected and an inflammatory 
reaction develops in adjacent viable tissue. The necrotic remains are ultimately 
removed by mononuclear phagocytes.
1.2.3 Characteristics of apoptosis
Apoptotic cell death typically occurs in scattered cells and progresses so rapidly that 
it is often difficult to observe. The first detectable change is the compaction of 
chromatin into crescent shaped areas or dense masses that abut onto the nuclear 
envelope. The cytoplasm of a cell condenses. Nuclear DNA undergoes characteristic 
changes. Double strand cleavage occurs at the linker regions between nucleosomes to 
produce fragments which are multiples of 185 base pairs (Wyllie, 1980; Arends et al.,
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1990). DNA degradation is specific since there is no apparent proteolysis of histones 
or other nuclear proteins (Wyllie et al., 1986) and the nuclear matrix of apoptotic cells 
remains unaltered (Arends et al., 1990). The near-universal presence of 
internucleosomal cleavage in apoptotic cells suggests that there may be a common 
mechanism by which apoptosis occurs in different cell types, and also that DNA 
fragmentation is an important part of the cell death mechanism. In exceptional 
circumstances key morphological features of apoptosis may be observed in the absence 
of internucleosomal DNA fragmentation (Collins et al., 1992), or DNA fragmentation 
may only be barely detectable at advanced stages of apoptosis (Zakeri et al., 1993).
To date, several candidate molecules for the apoptotic endodeoxyribonuclease 
responsible for internucleosomal DNA cleavage have been characterised or detected in 
various tissues or cell lines. They include a 130 kDa anionic protein with DNase 
activity (Arends et al., 1990), NUC-18 and a calcium dependent DNase (Alnemri and 
Litwack, 1990). DNase 1 has also been implicated (Pietsch et al., 1992: Ucker et al.,
1992), as have DNase II and NUC 1 (Barry and Eastman, 1993). Several studies have 
shown the endonuclease responsible for apoptotic cleavage of DNA to be calcium and 
magnesium dependent and inhibited by zinc (Cohen and Duke, 1984). The 
endonuclease responsible for apoptotic DNA cleavage has not yet been fully purified 
and characterised and so no general concensus of opinion exists as to its identity 
(Giadio and Cidlowski, 1991; reviewed by Schwartzman and Cidlowski, 1993).
As the compaction of chromatin continues, electron microscopic studies show 
the nuclear and cellular boundaries becoming more convoluted. Within the nuclei, 
chromatin usually becomed distributed as periperal crescents. At this stage vesicles are 
then extruded from the main body of the cell and are known as apoptotic bodies.
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These vesicles are membrane destinedand of different sizes containing some intact 
organelles. The apoptotic bodies may or may not contain fragments of chromatin. 
When the apoptotic bodies are released from the surface of single layer epithelium 
systems they are either taken up rapidly by adjacent cells and degraded by lysosomes, 
or are engulfed by neighbouring macrophages (Savill et al., 1993). The swift and 
efficient engulfment of the dead cell ensures macromolecules are not released from the 
dying cells provoking an immune response. Surrounding cells will close ranks so cell 
deletion occurs without disrupting tissue architecture. There is no inflammation and 
so the process is histologically remarkably inconspicuous.
1.3 Regulation of apoptosis
In some situations the presence of a protein synthesis inhibitor will prevent apoptosis, 
suggesting protein synthesis is a requirement of apoptosis (Cohen and Duke, 1984; 
Wyllie et al., 1984; Compton et al., 1988). In other situations, protein synthesis 
inhibitors do not prevent apoptosis (Waring, 1990; McCall and Cohen, 1991) 
suggesting all the proteins necessary for apoptosis are already present. Indeed in some 
situations protein synthesis inhibitors have been reported to induce apoptosis (Martin,
1993). These conflicting results suggest that cells may be in different stages of 
preparedness for apoptosis (Ledda-Columbano et al., 1992; Martin, 1993) or that 
protein synthesis may be essential for initiation only by certain types of stimuli and it 
is not an absolute requirement for execution of the process (Zacharchuck et al., 1990; 
Iseki et al., 1991). Alternatively it is possible that protein and RNA synthesis is 
required for the regulation of apoptosis rather than for synthesis of components of the
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programme itself.
1.4 Mechanism of apoptosis
The mechanism of apoptosis has not been elucidated. However, changes in the 
expression of certain genes are known to be a feature of apoptotic deaths. Although 
tissue specific gene expression may contribute to the extent of apoptosis in particular 
tissues, some changes in gene expression are universal and these form the general 
mechanism of apoptosis.
It is not yet clear if the events during apoptosis are directly coupled, so that 
one event triggers the next, or whether individual steps in the sequence are controlled 
independently by a cytoplasmic control system, as occurs during cell cycle regulation. 
Indeed, there are similarities between the mechanisms controlling the cell cycle and 
apoptosis. Perhaps the most important genetic changes observed during apoptosis are 
changes in the pattern of expression of proto-oncogenes and anti-oncogenes that control 
the cell cycle (Columbel et a l., 1992). From this evidence it appears that the cell cycle 
and apoptosis share a common regulatory pathway that diverges at some point where 
a cell either divides or dies.
Of the many oncogenes that influence cell cycle control, to date, the roles of 
bcl-2 and p53 are perhaps the most interesting with respect to apoptosis.
1.4.1 Regulatory role of bcl-2 in apoptosis
There is more evidence to document the role of the bcl-2 gene than any other known 
to be involved in apoptosis. Bcl-2 is a proto-oncogene, i.e. a gene whose excessive
activity will provide a cell with a selective advantage. Bcl-2 achieves this effect by 
inhibiting the apoptotic pathway (Garcia et al., 1992; Vaux et al., 1992). Likewise 
decreased Bcl-2 protein levels render cells more prone to apoptotic death (Miyashita 
and Reed, 1993). Bcl-2 represents a novel oncoprotein which appears to enhance cell 
lifespan but therefore may in consequence predispose these cells to carcinogenesis.
Bcl-2 protein has been detected in most tissues where apoptotic turnover and 
remodelling are important, and in these tissues expression is restricted to cell 
populations with a naturally lengthy lifespan (Hockenbery et al., 1991). Within cells 
Bcl-2 protein may have more than one form (Tsujimoto and Croce, 1986) with different 
cellular locations (Monaghan et al., 1992; Jacobson e al., 1993) and different survival 
capacities (Tanaka et al., 1993).
The role of Bcl-2 appears to have been conserved throughout evolution. The 
molecular mechanisms controlling cell death by Bcl-2 in humans and by ced-9 in 
Caenorhabditis elegans may well be the same (Vaux et al., 1992). Although 
mechanism of Bcl-2 action is still unclear some genes which can regulateB cl-2 action 
have recently been identified. A bcl-2 related gene, bax, appears to act in opposition 
to Bcl-2 by formation of heterodimers in vivo (Oltvai et al., 1993). This suggests the 
ratio of bax to bcl-2 expression could be crucial in determining the fate of a cell.
Boise et al. (1993) have identified a bcl-2 related gene, bcl-x, that is thought 
to exhibit death repression activity through two gene products, Bcl-xs and Bcl-xl. 
Although precise details of the mechanism involved are unclear it is known that theB cl- 
xl protein displays remarkable amino acid and structural homology to Qcl-2. 
Immunohistochemical analysis using polyclonal antisera specific for detection of mouse 
and human Bcl-xl anc Bcl-xs detected Bcl-x immunoreactivity in a wide variety of cell
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types (Krajewski et al., 1994). This study revealed a more widespread pattern of bcl-x 
expression than northern analysis had previously shown (Boise et al., 1993). The 
tissue patterns of Bcl-x expression were often different from those reported for Bcl-2 
suggesting that perhaps Bcl-2 and Bcl-x regulate cell life and death at different stages 
of cell differentiation (Krajewski et al., 1994). Bcl-x immunostaining was reported in 
both mouse and human mammary cuboidal epithelial cells lining the alveoli and ducts 
and in myoepithelial cells, occasional fibroblasts in surrounding stromal tissue were 
also reported to stain positively (Krajewski et al., 1994).
Another form of bcl-x mRNA, known as bcl-xfi, which is expressed in 
embryonal and postnatal tissues has also been identified (Gonzalez-Garcia et al., 1994). 
Further® cl-2 interacting proteins recently discovered include Bag-1, a protein which 
although shares no significant homology with Bcl-2 or other Bcl-2 family proteins does 
exhibit anti cell death activity (Takayama et al., 1995), and Bad, a protein with limited 
sequence homology to Bcl-2 that selectively dimerises withBcl-xl to reverse the death 
repressor activity ofBcl-xl (Yang et al., 1995).
Bcl-2 can modify the action of other proto-oncogenes such as c fos  and c myc, 
which are implicated in both cell proliferation and in cell death (Bissonnette et al.,
■s;
1992). The presence of Bcl-2 will inhibit apoptotic functions of these oncogenes 
leaving mitotic function unaffected (Fanidi et al., 1992). Thus bcl-2 dictates the 
outcome of the expression of other oncogenes in a cell. Indeed Bcl-2 can block p53 
induced apoptosis (Wang et al., 1993; Chiou et al., 1994).
1.4.2 Regulatory role of p53 , tumour suppressor oncogene in apoptosis
A tumour suppressor gene is defined as one which acts to inhibit growth and
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proliferation, such that loss of its function contributes to tumour progression. Tumour 
suppression can also be achieved if genes are able to induce apoptotic death in severely 
damaged cells that could otherwise proliferate in a disregulated manner. One gene with 
both of these abilities is p53.
P53 exerts its anti-proliferative effect by causing growth arrest in the G1 phase 
of the cell cycle, resulting in a Gl/S phase arrest (Diller et a l., 1990; Michalovitz et al., 
1990). During this arrest in the cell cycle any damage to DNA can be repaired (Kastan 
et al., 1991), but in severe cases of DNA damage p53 initiates apoptosis, and so 
prevents subsequent tumorigenesis.
P53 is not essential for life, since p53 null mice develop normally, but they 
are just more susceptible to tumourigenesis (Jacks et al., 1994). In mouse mammary 
gland, hyperplastic alveolar nodules (HANS) are the most common neoplastic lesion 
(Medina, 1988) and mutation of the p53 gene or altered expression of p53 protein was 
frequently observed in HAN outgrowths (Jerry et al., 1993). Mutations of the p53 
gene are one of the most commonly detected abnormalities in human cancer.
P53 is recognised as an important regulator of apoptosis (reviewed in 
Vogelstein and Kizler, 1992). In its mutated form p53 is more stable and has a longer 
half life than the wild type form and in this mutated state p53 is no longer competent 
to arrest the cell cycle. As a consequence cells containing potentially destructive DNA 
sequences are not removed, and damaged cells proliferate.
To date, two proteins have been shown to bind p53; these are GADD45 
(Kastan et a l., 1992) and mdm-2, a protein with oncogenic potential (Kern et a l., 1991; 
Levine et al., 1991; Wu et al., 1993). GADD45 transcription is increased in response 
to DNA damage, therefore levels of GADD45 increase as p53 levels also increase
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(Fomace et al., 1989). An increase in mdm-2 occurs in a p53 dependent manner 
(Barak et al., 1993) and the binding between the two gene products is not easily 
reversible (Barak and Oren, 1992). This suggests p53 and mdm-2 function in a 
feedback loop, to regulate the duration of cell cycle arrest following DNA damage 
(Chen et al., 1994).
P53 is also involved in modifying the action of other oncogenes. It has been 
shown to suppress expression of bcl-2 in the murine cell leukaemic cell line M l, while 
simultaneously stimulating an increase in bax expression (Mitashita et al., 1994). This 
identifies bcl-2 and bax as p53 regulated genes. Indeed mice deficient in p53 exhibit 
alterations in Bcl-2 and Bax protein levels in several tissues (Mitashita et al., 1994). 
Recently Miyashita and Reed (1995) suggested that bax is a p53 primary response 
gene, presumably involved in a p53 regulated pathway for induction of apoptosis.
1.5 Biological importance of apoptosis
There is now sufficient evidence to suggest that apoptosis provides a biologically 
meaningful function by regulating cell number and serves as a process to eliminate cells 
whose survival might be harmful to the animal.
1.5.1 Apoptosis during fetal life
Many cells die during normal development in both vertebrates (Glucksmann, 1950) and 
invertebrates (Truman, 1984). These deaths appear to be an integral part of 
morphogenesis and metamorphosis (reviewed in Ellis et al., 1991). The most widely 
reported programmed cell death during embryonic and foetal development is the death
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of cells during development of the nematode worm, Caenorhabditis elegans. To make 
a worm 1091 cells must be generated and 131 of these must die at pre-ordained times 
(Sulston and Horvitz, 1977). Cells of many different types die in this process. In 
many cases the life span of a condemned cell, from genesis to death, is less than an 
hour. (Yuan and Horvitz, 1990).
1.5.2 Apoptosis regulates tissue mass
Apoptosis also plays a vital role in regulating adult tissue mass. The process of 
apoptosis is particularly prevalent in slowly-proliferating cell populations, such as liver 
epithelium (Kerr et al., 1972) and in adrenal cortex epithelium (Wyllie et al., 1973), 
where it plays an opposing role to mitosis in the regulation of tissue size. Over a 
period of time the rates of the two processes will balance each other, so tissue mass 
remains stable, i.e. there is homeostasis. Apoptosis has also been reported to occur 
in more rapidly proliferating cell populations, such as in intestinal crypt epithelium 
(Potten, 1977) and in differentiating spermatogonia (Allan et al., 1987). In these 
systems apoptosis will occur as cells are shed or are lost due to migration, and the rate 
of mitosis must then match the rate of apoptosis for tissue mass to remain stable.
“-v.
1.5.3 Apoptosis regulating disease progression
Tumour development may result from disruption of the apoptotic pathway to confer a 
survival advantage. Apoptosis is also well recognised as a distinct pathological 
mechanism in tumours responding to anticancer therapies (Eastman, 1990), and so 
manipulation of apoptosis in tumour cells holds promise for successful cancer therapy 
(Williams, 1991).
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In the immune system cell morphogenesis is under apoptotic control (Duke et 
al., 1986; Lucas et al., 1991: Stacey et al., 1985; Waring, 1990). The removal of 
neutrophils from inflammatory sites involves macrophage recognition and apoptosis 
(Savill et al., 1989, Savill, 1990), and this prevents release of granule contents so 
tissue injury associated with inflammation is limited. This may prove a useful point 
of therapy for autoimmune or chronic inflammatory disease, such as rheumatoid 
arthritis.
1.5.4 Apoptosis in tissue involution
Tissue involution due to physiological development or pathological change is often 
apoptotic in nature. Pathological conditions such as the reduction in parotid tissue after 
ductal obstruction (Walker et al., 1976) or acute infantile spinal muscular atrophy 
(Fidzianska et al., 1990) result in apoptosis of otherwise healthy tissue. Non- 
pathological tissue involution often represents a natural and genetically-programmed 
event during which healthy tissue is removed from the organism because its functioning 
is no longer required. Overian follicular atresia (O’ Shea et al., 1978), removal of the 
endometrium at oestrous (Sandow et al., 1979) and death of hair follicles (Weedon and 
Strutten., 1981) are all examples of apoptotic cell death resulting in the removal of 
tissue no longer serving an essential function.
1.6 Apoptosis in mammary tissue
The removal of mammary tissue after weaning of the young is a programmed event 
which prevents the unnecessary channelling of energy into unwanted milk production.
12
Mammary epithelial cells have been reported to die by apoptosis when involution of 
the gland occurs (Walker et al., 1989). Mammary apoptosis is reviewed in detail in 
section 1.12.
1.7 The purpose of mammary development
To study the apoptotic process in the mammary gland some understanding of the 
development and function of the mammary gland is required. The principal function 
of the mammary gland is the production of milk for the nourishment of the young. 
The basic principle underlying the whole of mammary development, therefore, is that 
the mammary glands must be capable of producing milk of a quantity and composition 
which is appropriate to the needs of the young throughout their pre-weaning 
development. A relationship between the number of fetuses carried and mammary 
growth or milk yield have been demonstrated in a number of species (rats; Tucker, 
1966; sheep; Rattray et al., 1974; goat; Hayden et al., 1979). Young mice are capable 
of influencing mammary development both pre partum and post partum (Knight and 
Peaker, 1982b). This is perhaps particularly important in communally nesting species, 
such as mice.
1.7.1 Domestic and laboratory species
This basic principle has been modified somewhat in dairy species, in that both the yield 
and composition of milk produced, and hence the gland’s development, have been 
altered to suit man’s own requirements, rather than those of the young. This has been 
achieved by a combination of selective breeding and adjustment of the animal’s
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physiology, normal habitat, environment and diet. The majority of laboratory species 
have also been selectively bred and this may have altered their natural pattern of 
mammary development. Particularly appropriate examples are strains of mice which 
have been bred for tumour susceptibility.
1.8 The pattern of mammary development
Unlike most other tissues, mammary gland development is not fully complete at 
puberty. In rodents and ruminants there are two distinct phases of gland development. 
Prior to pregnancy the gland is only poorly developed and consists mainly of ducts and 
fat, with some lobulo-alveolar secretory tissue. At this time, waves of cell proliferation 
and regression coincide with oestrus and luteal phases, respectively, of the oestrus 
cycle of pubertal animals (Sinha and Tucker, 1969). Cyclical fluctuations in cell death 
also occur throughout the menstrual cycle in human breast tissue (Ferguson and 
Anderson, 1981). After first conception mammary development consists of periods of 
proliferation, secretion and involution to coincide with pregnancy, birth, growth and 
weaning of successive litters.
The rate of milk synthesis by the mammary gland changes throughout lactation 
in response to many factors, including nutrition of the animal, circulating hormones and 
also local intramammary factors. It is the number and activity of secretory cells that 
determine the capacity for milk synthesis. Previous studies in the mouse have shown 
that changes in mammary cell number both in pregnancy and during established 
lactation play a significant role in attaining peak milk yield and its subsequent decline 
at weaning (Knight and Peaker, 1982a).
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1.8.1 The lactation cycle
Each lactation cycle involves three overlapping stages. The first of these is the growth 
phase, termed mammogenesis when there is extensive proliferation of secretory cells 
during gestation and during early lactation. In rats and mice there is a 2-3 fold 
increase in the size of the secretory cell population during gestation (Munford, 1963).
The second phase is lactogenesis, the development of the capability for 
synthesis of milk components during late gestation (lactogenesis stage I) followed by 
the onset of copious secretion at around parturition (lactogenesis stage II; Fleet et al., 
1975). This process of milk secretion is referred to as galactopoiesis.
The third phase, involution, is designed to remove excess mammary mass 
from the mother. It commences in late lactation, when the young are no longer 
entirely dependent upon their mother for nutrition. There is a gradual loss of cells, the 
rate of which is accelerated dramatically once the young are weaned and lactation has 
ceased (Ota, 1964). The extent of tissue removal during involution may vary from 
species to species (Hurley et al., 1989), but in rodents the mammary gland reverts to 
a small, relatively quiescent structure similar to that found at the start of pregnancy 
(Walker et a l., 1989).
1.9. Phases of mammary development 
1.9.1 Mammary development during gestation
In the later stages of pregnancy mammary weight increases progressively in mice, rats 
and goats. Methods to determine the size of a mammary population assume DNA 
content per cell is constant and that changes only occur in one cell type, i.e. the
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epithelial cell population and not fat or connective tissue cell populations (Paape and 
Sinha, 1971). During pregnancy the alveolar epithelium begins to bud out from the 
branching duct system and replaces the fatty stroma. In mice, total mammary DNA 
increases exponentially in this period, doubling time being 6 days in mice at late 
gestation (Knight and Peaker, 1982a). Cell proliferation, as measured by tritiated 
thymidine incorporation is highest at mid-pregnancy in mice and falls slightly at the end 
of gestation (Knight and Peaker 1982a). Similar observations were made in rats 
(Munford, 1963) where 60% of mammary development occurs during pregnancy 
(Griffith and Turner, 1961).
In mice, 8 casein appears at approximately day 8 of pregnancy, whey acidic 
protein at approximately day 14, and a lactalbumin may only be synthesized 
immediately after parturition (Goodman and Schanbacher, 1991) although very low 
levels of a-lactalbumin have been detected in the blood of pregnant animals, prior to 
tight junction formation between mammary epithelial cells (Mao and Bremel, 1990;
1991). In rats and pigs, a-lactalbumin is synthesized prior to parturition (Wilde and 
Kuhn, 1979; Buttle, 1993).
An increase in the size of the mammary population in ruminants occurs during 
gestation, but this growth rate is slower than that of rodents, reflecting the difference 
in both the size of the glands and the length of gestation (Anderson et al., 1982). At 
the end of gestation, cellular differentiation commences (Wilde et al., 1986) and 
epithelial cell size increases (Foster, 1977) possibly as a result of accumulation of 
secretion.
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1.9.2 Mammary development during lactation
1.9.3 Mice
During early lactation mammary weight increases progressively in rodents (Tucker & 
Reece, 1963; Traurig, 1967). In mice this increase in mammary mass is apparent until 
day 10 of lactation and coincides with an increased milk yield over the same period. 
Peak milk yield is attained on day 10-15 of lactation (Knight and Peaker, 1982a, 
Shipman et a l., 1987). Proliferation studies using tritiated thymidine demonstrate DNA 
synthesis during the first five days of lactation (Knight & Peaker, 1982a) suggesting 
post partum growth is a mechanism of adjusting the milk yield to the milk requirement 
of the suckling young (Knight and Peaker, 1982a). Indeed, mammary growth can also 
be stimulated by increasing the number of young in a litter, but this effect is only 
apparent during the first few days of lactation (Knight at al., 1986). This may be 
important for those species, such as mice, which have a communal existence and cross- 
suckle (Matthews, 1952). Until day 5, cell hypertrophy is modest compared to the 
extent of cell proliferation indicating that the increase in milk yield may be ascribed to 
increased cell proliferation rather than increased synthetic capacity per cell (Shipman 
et al., 1986; 1987). After 5 days any increase in milk yield is most likely to be 
attributable to hypertrophy of secretory cells (Shipman et al., 1986: 1987).
1.9.4 Rats
In rats between days 2 and 7 of lactation milk yield increases by 80%, cell number by 
55% (Knight et al., 1984). At this time the elevation in milk yield is attributable to 
cell number and cell differentiation. During the second week of the lactation cycle 
milk yield increases a further 20% and cell number increases by 20% (Knight et al
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1984). Therefore milk yield increases to a peak at day 14 as does the size of the 
mammary population along with the DNA:RNA ratio (Knight et al., 1984). In rats 
beyond day 16 of lactation milk yield falls.
1.9.5 Goats
In goats over the first three weeks of lactation both milk yield and DNA content of the 
gland (a measure of the size of a mammary population) increase (Anderson et al., 
1981; Knight & Peaker, 1984), and mammary cell proliferation does not cease at 
parturition in goats but continues into the early stages of the lactation cycle (Knight and 
Peaker, 1984). Between weeks 3 and 8 although the size of the mammary population 
remained constant, yield steadily increased over this period to reach a peak at around 
week 8 of lactation (Blatchford and Peaker 1982; Knight and Peaker, 1984). This 
increase can be attributed to an increase in cell differentiation (Wilde et al., 1986). In 
goats a steady decline in milk yield occurred between weeks 8 and 23. The size of the 
mammary cell population falls by some 30% and mammary udder volume falls over 
this period in line with decreases in milk yield observed in these animals (Knight and 
Peaker, 1984).
1.9.6 Mammary cell loss during tissue involution
Natural involution is a gradual process which commences during declining lactation as 
the young start to eat solid food. When suckling ceases involution is accelerated. 
Involution of the lactating human breast following weaning is accompanied by a rapid 
decrease in weight (Ota, 1964: Carlsson et al., 1973; Helminen et al., 1968), in the 
proportion of the organ occupied by glandular parenchyma (Williams, 1942; Wellings
18
and Deome, 1963; Richards and Benson, 1971), and in total DNA content (Griffith and 
Turner, 1962; Tucker and Reece, 1963; Ota, 1964; Carlsson et al., 1973). During 
mammary involution there is also a reduction in cell size (Helminen and Ericsson, 
1968; Brandes et al., 1969; Richards and Benson, 1971; Wellings and Deome, 1963).
1.10 Control of mammary development
1.10.1 Control of mammary development during gestation
During pregnancy, mammary growth is stimulated by a combination of steroids and 
polypeptide hormones. The steroids include a mixture of oestrogens, which are 
responsible for increasing the number of proliferating cells while decreasing the time 
required for cell division in mice (Bresciani, 1971) and in rats (Grahame and 
Beralanffy, 1972).
Polypeptide hormones also regulate mammary growth during gestation. These 
protein hormones include prolactin, growth hormone and placental lactogen, the 
contribution each plays pre-partum varies according to the species. In many species, 
placental lactogen is secreted by the placenta and is a major contributor to lactogenic 
activity during gestation in ruminants (Kelly et al., 1976; Forsyth, 1986; Collier et al., 
1995), while in others placental lactogen is secreted in such minute amounts as to make 
no significant difference to mammary development (Cowie et al., 1980). Placental 
lactogen levels are higher in animals carrying a large number of foetuses, resulting in 
a degree of mammary growth appropriate to the needs of the young (Knight and 
Peaker, 1982b; Flint et al., 1995). Mammogenesis is induced by placental lactogen, 
however the mechanism involved is presently unclear, and probably does not involve
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prolactin, IGF-1 or somatotrophin receptors (Collier et al., 1995).
In women placental lactogens are present in substantial amounts in the second 
half of pregnancy (Franks et al., 1977, Nielson et al. 1979; Prichard et al., 1985). In 
mice and rats coitus results in twice daily prolactin surges and in rising prolactin levels. 
In ruminants prolactin levels remain low until a few days before parturition as in goats 
placental lactogen is largely responsible for the lactogenic activity and levels of this 
hormone to rise prior to mid-pregnancy and plateau between day 110 and parturition 
at day 150 (Knight et al., 1982a). Rising levels of prolactin at parturition offsets the 
loss of plactental lactogen from the system (Cowie et al., 1980).
1.10.2 Control of mammary development in lactation
Control of mammary development involves a complex hierarchy of interacting 
mechanisms including regulation by systemic endocrine control, regulation exerted by 
any foetuses in utero and by the degree of suckling post partum . Finally, the influence 
of environment, diet and the metabolic status of the mother are also crucial to the 
overall development pattern during lactation.
Lactation is maintained by hormonal influences which differ between species. 
In rodents it was thought that primarily prolactin and not growth hormone regulated 
both lactogenesis and galactopoiesis. However, it has been shown that growth hormone 
increases in importance as lactation progresses (Flint et al., 1992), particually when 
circulating prolactin concentrations are low (Madon et al., 1986; Barber et al., 1992; 
Flint et al., 1992). Recently a local galactopoitic effect of growth hormone has been 
demonstrated in rats (Flint and Gardiner, 1994) which cannot be mimicked by IGF-1, 
or IGF-2, IGF analogues or complexes of IGF’s and binding protein (Flint et al.,
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1994), showing that growth hormone is acting via an IGF independent pathway.
In ruminants it is growth hormone and not prolactin which provides the main 
galactopoietic stimulus (Karg et al., 1972; Hart and Flux, 1973). Growth hormone can 
maintain milk secretion in the absence of prolactin in hypophysectomized lactating 
goats (Cowie et al., 1964), and stimulates milk production in intact goats (Knight et 
al., 1990) and cows (Bauman et al., 1985).
Despite extensive study of the mechanisms of hormone action in the mammary 
gland, the mode of growth hormone and prolactin action is unclear. A number of 
experiments in vitro using mammary tissue explants and isolated cells have shown that 
the expression of the genes for the major milk proteins, the caseins, are regulated by 
prolactin at the level of transcription and mRNA stability (Guyette et al., 1979). 
However, casein mRNA is detected in the rat during pregnancy at a time when serum 
prolactin is relatively low (Rosen and Barker, 1976). The factor that confers prolactin 
stimulation to milk protein gene transcription has recently been identified as mammary 
growth factor (MGF) or STAT5 (Liu et al., 1995). This is a transcription factor that 
becomes activated by a tyrosine specific protein kinase, Jak 2. Tyrosine 
phosphorylation converts STAT5 from a latent factor into one with DNA binding and 
transcriptional potential (Groner and Gouilleux, 1995). The regulation of MGF / 
STAT5 in vitro and in vivo indicate that it is a central component of the lactogenic 
hormone signaling pathway (Ashkenas et al., 1995; Kazansky et al., 1995; Streuli et 
al., 1995b).
Growth hormone can produce a local mammogenic response when infused into 
individual glands of pregnant heifers (Collier et al., 1993) and the mitogenic effects of 
growth hormone have been confirmed in goats using in vivo bromodeoxyuridine
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Growth hormone receptor mRNA has been identified and characterised in many organs 
including the mammary glands of many species (Jammes et al., 1991; Tiong and 
Hermington, 1991). The expression of growth hormone receptor mRNA was subject 
to gestational, developmental and tissue specific regulation (Ilkbahar et al., 1995).
labelling to quantify cell proliferation (Knight et al., 1994). However the growth 
hormone receptor has not yet been demonstrated on mammary epithelium (Akers,
1985). It is likely that the mammogenic effect of growth hormone is mediated by IGF- 
1, a recognised mammary mitogen (Winder and Forsyth, 1986). The IGF-1 receptor 
is thought to be present in mammary stromal tissue (Hauser et al., 1990), and growth 
factors including IGF-1 administered locally can elicit a growth response in mammary 
tissue (Collier et al., 1993).
1.10.3 Co-ordination of mammary involution
Mammary epithelial cells are removed from the gland at the end of a lactation cycle. 
Dying mammary epithelial cells have been reported to show nuclear changes, which 
have since been shown to be characteristic of cells undergoing apoptosis (Wellings and 
Deome, 1963; Martinez-Hernandez et al., 1976). Epithelial cells in involuting tissue 
were lysed after being shed into the lumen (Wellings and DeOme, 1963; Richards and 
Benson, 1971). Myoepithelial cells have variously been reported to show little change 
(Helminen and Ericcson, 1968; Radnor, 1972) in some studies, and to undergo 
cytolysis in a manner similar to epithelial cells in other studies (Wellings and DeOme, 
1963). Rapid shrinkage of the capillary bed is known to accompany regression of the 
mammary parenchyma (Williams, 1942), but how this is accomplished is unknown.
Loss of the suckling stimulus results in decreased production of lactogenic 
hormones, milk stasis within the gland (Wilde et al., 1995a) and the expression of 
metalloproteinases (Strange et al., 1992). During involution the alveolar structure 
disintegrates and the basement membrane is removed by ECM-degrading 
metalloproteinases. A delicate balance between the expression of these proteinases and
22
their inhibitors controls the breakdown of gland structure (Talhouk et al.,. 1991, 1992). 
Initially, the proteinases are inhibited by a temporary increase in inhibitors, which 
prevents the immediate breakdown of the basement membrane. After a few days, 
tissue inhibitor of metalloproteinases (TIMP) expression decreases while 
metalloproteinase expression remains, this favours degradation of the basement 
membrane (Strange et al., 1992). During the involution process milk protein synthesis 
is switched off and is accompanied by regression of the alveoli and a reduction in tissue 
mass. This remodelling process leads to a phenotype similar to that seen in the virgin 
animal (Walker et al.,1989).
1.11. Basement membrane control of mammary function
Many cells require interaction with basement membrane for full differentiation 
and function. In these systems gene expression and controlled differentiation are reliant 
upon cell-extracellular matrix (ECM) interactions. In the hepatocyte albumin gene 
expression is due to control by laminin (Bissell et al., 1987, Liu et al., 1991) and in 
the skin, terminal keratinocyte differentiation occurs when basement membrane contact 
is lost in suprabasal layers (Watt et al., 1988; Kubler et al., 1991).
Mammary cells cultured on plastic dishes fail to produce milk proteins even 
under hormonal conditions optimal for lactation. In contrast, when these cells are 
cultured on an extracellular matrix extracted from Engelbreth Holm Swarm tumour 
(EHS) containing laminin, collagen I and IV, fibronectin and vitronectin, these cells 
recreate their alveolar structure and synthetic phenotype (Aggeler et al., 1991; 
Barcellos-Hoff et al., 1989; Li et al., 1987). Mammary epithelial cells plated onto
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EHS secrete caseins and whey acidic protein unidirectionally into the sealed central 
lumina (Barcellos-Hoff et a l., 1989; Chen and Bissell, 1989). Transferrin, on the other 
hand, as in vivo, is secreted bidirectionally and in culture is recovered in the lumina 
and culture medium (Barcellos-Hoff et al., 1989; Chen and Bissell 1989).
1.12. Apoptosis during mammary involution
1.12.1 Initial identification of mammary apoptosis
At the start of this study, in October 1992, mammary apoptosis had been shown to 
occur during involution of rodent mammary tissue at the end of lactation (Walker et 
al., 1989) and after litter removal at peak lactation (Walker et a l., 1989; Strange et a l.,
1992). The sequence of events during apoptosis were studied by light and electron 
microscopy (Walker et al., 1989), by detection of DNA laddering (Strange et a l., 1992) 
and by changes in mammary gene expression (Strange et al., 1992). From these 
studies apoptosis was shown to occur in epithelial, myoepithelial and endothelial 
mammary cell populations (Walker et al., 1989). After weaning, macrophages in the 
tissue were found to increase in size as they became filled with lipid vacuoles and 
lipofuscin pigment granules due to phagocytosis of apoptotic bodies (Walker et al., 
1989). DNA laddering, visualised by the rather insensitive ethidium bromide method 
detected laddering one day post-weaning when litter removal occurred at peak lactation 
and laddering increased to a peak at 4 days before decreasing to barely detectable levels 
at six days post weaning (Strange et al., 1992). Control of apoptosis by prolactin 
demonstrated the hormonal dependence of apoptosis in mammary tissue (Sheffield and 
Kotolski, 1992).
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The timings of these changes coincided with changes in the pattern of gene 
expression in mammary tissue. Strange et al., (1992) extracted RNA from involuting 
glands and analysed for the expression of genes associated with
1) epithelial differentiation - ft casein, whey acidic protein
2) tissue remodelling - T1MP, stromelysin
3) stress and cell death - heat shock protein 70, tissue transglutaminase
4) regulation of cell proliferation and diferentiation - c myc, p53, TGF f t
Expression of ft casein and whey acidic protein were dramatically reduced 
during involution induced by litter removal at peak lactation (Strange et al., 1992). 
Changes in the expression of proteases were detected within the initial two days post 
weaning, whereas protease inhibitor levels remained high until three days post weaning. 
At 6 days post weaning protease levels fell, whilst levels of inhibitors rose (Strange et 
al., 1992). Genes involved in the stress responses were induced by weaning as where 
genes associated with regulation of cell growth and differentiation (p53 and TGF ft at 
1 day post weaning; c myc at 4 days post weaning; Strange et al., 1992).
1.12.2 Characterisation of mammary gene expression associated with apoptosis
Study of gene expression during mammary involution has identified changes in known 
and uncharacterised genes in the process of mammary apoptosis. For example, 
weaning induced a decrease in the expression of poly (ADP-ribose) polymerase during 
mammary apoptosis (Guenette et al., 1994) and the immediate early genes c fos  and 
c jun  are also elevated during the early stages of mammary apoptosis (Marti et al., 
1994). Differential display techniques identified a range of genes with altered 
expression patterns during the early stages of mammary apoptosis. One of these is the
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gas 1 gene which is upregulated during mammary involution (Bielke et al.,1995) and 
appears to exert its effects through p53 by causing growth arrest (Schneider et al., 
1988, Del Sal et al., 1992). It may be induced by loss of cell adhesion to extracellular 
anchors.
Further studies using sophisticated cell culture techniques have demonstrated 
the importance of integrin mediated control of mammary development (Streuli et al.,
1993) and a role for bcl-2 and bax have been demonstrated during mammary involution 
(Edwards et al., 1995). Recent cell culture experiments have demonstrated the 
importance of interleukin (IL) 18 converting enzyme (ICE) during mammary apoptosis 
(Boudreau et al., 1995). This enzyme is a protease which cleaves pro IL-lfl to 
generate mature IL-lfl. ICE is homologous to proteins that have been implicated in 
apoptosis in other systems, including ced 3 (Yuan et al., 1993).
1.13 Aims of this project
Research to date has shown that mammary cell loss during tissue involution 
is by apoptosis, and that this process is at least in part, under endocrine control. 
Characteristic changes in gene expression during apoptosis have served to identify at 
least some of the events likely to control this process during involution. There has, 
however been very little knowledge of the process of apoptosis in mammary tissue and 
very little published information in this area. Involution and apoptosis had almost 
without exception been induced by litter removal (Walker at al., 1989; Strange et al.,
1992) or natural weaning (Walker at al., 1989) in rodents; whether similar events occur 
under more natural concurrent pregnancy conditions is unclear. A comparision of the
extent and timing of events during the apoptotic process has not been performed. 
Likewise, virtually nothing is known about the regulation of mammary apoptosis. The 
extent of DNA laddering in mammary tissue has been determined by several 
investigators using insensitive ethidium bromide staining techniques, and it has 
therefore been perceived that apoptosis has either only been restricted to tissue 
involution or that internucleosomal nicking has not been an important feature of 
mammary apoptosis.
To address these areas in this project I have compared the time-
course and extent of apoptosis in rodents after induction by litter removal at both peak 
and declining lactation and during natural weaning. Events were also compared to 
those observed during concurrent pregnancy, to determine the necessity of apoptosis 
in this situation and to build a more comprehensive picture of the role of apoptosis in 
rodent mammary tissue.
Besides determining the importance of apoptosis throughout lactation and 
involution, some of the extracellular and intracellular factors that regulate apoptosis 
were also investigated. It is likely that factors responsible for regulation of lactation 
are also involved in control of apoptosis.
S -
Endocrine regulation of lactation has been well established, and manipulation 
of mammary apoptosis by prolactin had been previously reported (Sheffield and 
Kotolski, 1992). Investigation into the effectiveness of prolactin and growth hormone 
on altering the rate of mammary apoptosis aimed to provide information about the 
hormonal regulation of apoptosis and also to show the relative importance of these two 
hormones during rodent lactation.
Lactation is also regulated by local control mechanisms. For example, frequent
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milking in goats has been demonstated to alter milk yield and mammary cell number 
(Henderson et al., 1983, 1985; Knight and Wilde, 1987; Wilde et al., 1989, 1991). 
Milk stasis had been shown to control milk secretion, and furthermore a constituent of 
milk has been isolated and shown to regulate milk secretion by autocrine feedback 
inhibition (Wilde et al., 1995a). Therefore the possibility of regulation of apoptosis 
by local mechanisms resulting from milk stasis were investigated.
Although the role of apoptosis in rodents has been studied at least to some 
extent, the importance of apoptosis during involution of mammary tissue in other 
animals was unknown. Despite extensive study of the lactation cycle of ruminants, 
with a view to extending the lactation cycle of dairy animals or improving milk yield 
during lactation, the role of apoptosis during lactation and involution has not been 
determined. It has been suggested that the extent of cell carryover between lactation 
cycles in ruminants may be minimal compared to the situation in rodents, implying that 
cell death may not be an important feature of ruminant involution (Hurley et al., 1989). 
Knowledge of the extent of apoptosis during involution of ruminant mammary glands 
will bring greater understanding of the mechanisms operating within mammary tissue 
during involution of the gland. This may suggest strategies for controlling mammary 
cell number and potentially for extending lactation in dairy animals or altering cell 
carryover between lactation cycles to improve subsequent milk production.
Throughout lactation cell number changes in a controlled manner, and in the 
goat a substantial decrease in cell number has been noted during the declining phase 
of lactation (Knight and Peaker, 1982 a,b). This raises the possibility that apoptosis 
may be responsible for cell removal during this declining phase of lactation. Indeed 
apoptosis may even prove to be an important regulatory mechanism at all stages of
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lactation. A more successful adjustment of mammary cell number during lactation 
may be possible once the interplay between proliferation and death mechanisms has 
been determined. This would allow lactation to be more finely tuned than is presently 
possible.
The dynamic balance between mammary proliferation and cell death the 
occurence and extent of mammary apoptosis has been studied in this project in rodents 
and ruminants in vivo. However to understand more about the regulation of mammary 
apoptosis it is most likely that the use of mammary cell culture systems will prove 
advantageous. The employment of cell culture models allows the use of a more 
precisely defined and less complex system than in vivo. Unfortunately normal 
mammary cells are both stucturally and functionally compromised in many of the 
mammary cell culture systems that are in regular use (Ip and Darcy, 1996). In 
particular in monolayer culture studies neither differentiation nor alveolar structure is 
maintained and synthesis of whey acidic protein, an important milk constituent, is not 
achieved by monolayer culture of epithelial cells despite hormone conditions optimal 
for milk secretion (Chen and Bissell, 1989). However one cell culture system has been 
developed whereby epithelial cells are cultured on a layer of reconstituted basement 
membrane (Barcellos-Hoff et al., 1989; Chen and Bissell, 1989; Streuli and Bisssell, 
1990; Aggeler et al., 1991). In this environment epithelial cell are polarised and 
secrete milk in a similar manner to mammary epithelial cells in vivo (Li et al., 1987; 
Schmidhauser et al., 1990; Seely and Aggeler, 1991, Streuli et al., 1991). This 
system has become the one of choice when investigating mechanisms of milk 
production and secretion. It is hoped that mammary epithelial cells grown on 
reconstituted basement membrane will prove suitable for the study of apoptosis.
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CHAPTER TWO
MATERIALS AND METHODS 
2.1 Materials
2.1.1 Chemicals
Radiochemical were from ICN Flow, Irvine, UK. Cell culture media were purchased 
from either Gibco BRL Ltd., Paisley, UK or Northumbria Biologicals Ltd., 
Cramlington, UK. Molecular biology reagents were purchased from Promega, 
Southampton, UK or Boehringer Corp. Ltd., Lewes, UK. General laboratory
chemicals were supplied by Sigma Chemical Co, Poole, UK or BDH, Poole UK unless
- \
stated otherwise.
Mouse cDNA probe for stromelysin-1 was a gift from Dr. L.M. Matrisian, 
Department of Cell Biology, Vanderbilt University, Nashville, Tennessee, USA. The 
mouse cDNA probe for tissue inhibitor of metalloproteinase 2 (TIMP-2) was a gift 
from Dr. M. Cockett, Celltech Ltd., Slough, UK. cDNA probes for p53 were 
provided by Dr. T. Crook, Ludwig Institute for Cancer Research, London, UK and 
Professor M. Oren, The Weizmann Institute of Science, Rehovot, Israel, bcl-2 cDNA 
was a gift from Dr. Y. Tsujimoto, Osaka University Medical School, Osaka, Japan.
Water used in any molecular biological procedure was molecular biology grade 
from Sigma Chemical Company, Poole, UK.
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2.1.2 Animals
Mice derived from Tuck’s No. 1 strain (A Tuck and Sons, Battlebridge, UK) and 
female Wistar rats were provided with food and water ad libitum and housed as 
described previously (Knight et al. 1986). All animals were used in their first lactation 
unless stated otherwise. In mice and rats, litter size was adjusted to 10 pups on day 
1 of lactation (the day immediately following nocturnal parturition).
British Saanen goats from the Institute herd were routinely milked twice daily 
at approximately 08.00 and 16.00 h. They were fed 1.5-1.8 kg concentrates daily 
(16.5% crude protein, 12.5 MJ/kg; Goat mix No. 1, Edinburgh School of Agriculture, 
Edinburgh, UK), receiving half of the ration at each milking, with hay and water 
available ad libitum.
2.2 Experimental procedures 
2.2.1. Mouse experiments
Mouse litters were removed from the dam into a separate cage on day 10 or day 16 of 
lactation and mammary tissue was collected from the dam 0, 1, 2, 4 or 6 days 
thereafter.
Mammary tissue was also obtained from two groups of lactating dams on 
alternate days, between days 16 and 26 of lactation. The first group of dams was 
suckling their first litter, the second group of dams was mated at post partum oestrus 
and so the animals were lactating their first litter while pregnant with their second 
litter.
Mouse mammary teats were selectively sealed with tissue adhesive (Vetseal;
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Braun Melsungen AG, Melsungen, Germany) at day 10 of lactation. Pups were 
removed from the dam for 1-2 h while the sealant was allowed to dry, and the size of 
the litter was reduced on return to the dam to maintain a one pup to teat ratio. These 
pups were allowed to suckle ad libitum for 1 or 2 days, before the removal of 
mammary tissue.
2.2.2 Rat experiments
Experiments in three groups of rats commenced on day 12 of lactation. In the first
group litters were removed for 24 and 48 h in the first group. The effects of hormone
withdrawal were investigated in the second group. Prolactin was removed by daily
intraperitoneal injection of bromocriptine whilst anti growth hormone serum was
administered by daily subcutaneous injection to neutralise the effect of growth
hormone. Mammary tissue was taken after 24 and 48 h of individual or combined anti
hormone treatment. In the third group of rats the effects of hormone replacement were
determined in animals previously treated with bromocriptine and anti growth hormone
serum. Prolactin replacement or growth hormone replacement for 24 h was followed
by post mortem tissue collection. Tissue from treated rats was compared with lactating
rat mammary tissue collected on day 12, 13 or 14 of lactation.
Previous studies have demonstrated the efficacy of these treatments (Madon et al., 1986),
2.2.3 Goat experiments
Two experiments were performed in goats. In one experiment twelve goats were 
milked twice daily throughout lactation prior to a unilateral milking treatment in which 
one gland remained unmilked for up to 3 weeks whilst the other continued to be milked 
twice daily. After 2 days, 1, 2 or 3 weeks of treatment, post mortem tissue samples
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were taken from each mammary gland.
In a second experiment three groups of goats were allowed to suckle their 
young immediately after parturition, to establish milk secretion. These goats were then 
switched to one of three unilateral milking regimes for four weeks
1) the right gland milked three times a day; the left gland milked once daily
2) the right gland suckled by the kids ad libitum; the left gland milked once daily
3) the right gland drained continuously after insertion of a catheter into the teat 
canal; the left gland milked once daily.
Biopsy tissue was taken from each mammary gland prior to unilateral treatment in the 
first group of goats and from each mammary gland at the end of unilateral treatment 
in all three groups of goats.
2.3 Cell culture
2.3.1 Cell culture media
Mammary cells from mid pregnant mice were cultured as described previously 
(Blatchford et al., 1994). Details of the culture media are given in table 2.1. All 
media, pH 7.4, were sterilised through a 0.2 pm  pore filter (Gelman Sciences, 
Southampton, UK) prior to use. Hormones were prepared for addition to the culture 
media as follows:
Insulin (0.1 mg/ml) was prepared by dissolving 1 mg of insulin (from bovine pancreas,
24.4 I.U./mg) in 1 ml of water containing 10 /xl of 0.34 M  NaOH. This stock was 
made up to 10 ml with water and aliquots were filter sterilised and stored at -20°C. 
Cortisol (0.1 mg/ml) was prepared by dissolving 1 mg of cortisol (hydrocortisone-21-
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acetate) in 1 ml of ethanol. The solution was diluted to 10 ml in water and aliquots 
stored at -20°C.
Prolactin (from sheep pituitary, 32 I.U./mg) was prepared by dissolving lmg of oPrl 
in 250 fx\ of 10 mM Hepes (pH 8.0), diluted with water to 10 ml and aliquots were 
filter sterilised and stored at -20°C.
Triiodothyronine (T3) 0.65 mg was dissolved in 250 /lcI of 0 .34m  NaOH and diluted to 
10 ml with water. Aliquots (10 /xl) were filter sterilised and stored at -20°C, and 
diluted to 10 ml with water as required.
2.3.2 Preparation of mammary cells
Mice killed by cervical dislocation were rinsed in 70% (v/v) ethanol, prior to the
collection of mammary tissue (approximately 10 g). Excess milk was removed by
washing in 20 ml of Hanks buffer (pH 7.4) and the tissue was finely chopped using
curved scissors. Digestion was preformed in 40 ml of digestion medium (1 x Hanks
Basal Salt Solution, 1 x Minimum Essential Amino Acids, 5 mM glucose, 2 mM
glutamine, 4% bovine serum albumin. 5 ue / ml insulin, 1 jxg/ ml cortisol, 167 U / 
(Worthington Biologicals Ltd, U.K.) 
ml Collagenase class 111), using an orbital incubator (Gallenkamp, Loughborough,
UK) at 37°C and 120 rpm with agitation by pipette every 15 min. After approximately
100 min, when the cells were predominantly in clumps of 10-20 cells, the digest
mixture was filtered through a 150 ^m pore nylon mesh (Henry Simon Ltd., Stockport,
UK) held in a 45 mm filter support (Nalgene, Rochester, New York, USA). The cells
were harvested by gentle centrifugation (80 g, 4 min, room temperature), resuspended
in 20 ml of wash medium (1 x Hanks Basal Salt solution, 1 x Minimum Essential
Amino Acids, 5 mM glucose, 2 mM glutamine, 10 mM Hepes, 5 /xg / ml insulin, 1
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/xg / ml cortisol, 200 ycg / ml trypsin inhibitor, 40 U / ml DNase) and reharvested. 
This wash step was repeated three times. The final cell pellet was filtered through a 
50 /xm pore nylon mesh and resuspended in 5 ml of culture medium (1 x Medium 199,
1 x Hams F12, 21 mM Hepes, 0.4 % sodium bicarbonate, 5 ^g / ml insulin, 1 pig /ml 
cortisol, 1 pig / ml prolactin, 650 pg / ml Tri-iodothyronine, 1 mM glucose, 10 % 
foetal calf serum). Insulin levels were reduced to 0.5 pig / ml in experiments 
determining IGFBP levels to ensure insulin did not react with IGF receptors. Cell 
viability was assessed by trypan blue exclusion.
Cells were dispensed into 6 well plastic tissue culture plates (Costar, 
Cambridge, Mass., USA) and incubated at 37°C under 5% C 02 (v/v) in a saturated 
water atmosphere. After a 1 h equilibration period, the cells were harvested by 
centrifugation (80 g, 4 min) and resuspended in 2 ml of fresh incubation medium. 
Cells were layered onto a freshly prepared continuous Percoll gradient, (1.01 - 1.06 
g/ml) and separated by centrifugation according to density (80 g, 20 min). Layers 
containing mainly clumps of cells were pooled and cell yield was estimated from an 
aliquot of the cell suspension by comparision of the packed cell pellet volume after 
centrifugation (11,000 g, 30 s) with a predetermined standard.
Extracellular matrix, prepared in-house, was carefully thawed below 4°C, and 
dispensed into plastic tissue culture plates (2.5 ml matrix / 35mm diameter well). 
After spreading evenly at 4°C, the matrix was polymerised (15 min, 37°C). 1 x 106 
epithelial cells in 3 ml culture medium were then dispensed into each culture well. 
Culture medium, without foetal calf serum, was replaced daily.
Cells were harvested by replacing culture medium with 0.4 ml Dispase 
(Universal Biologicals Ltd., London, UK). After incubation (20 min, 37°C) cells
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released from the matrix were collected and centrifuged (1,000 g, 2 min), washed with 
0.5ml fresh culture medium, and again centrifuged (1,000 g , 2 min). The cell pellet 
was stored immediately in liquid nitrogen for subsequent analysis. Other cells were 
fixed for histological study by addition of freshly prepared 4% (w/v) paraformaldehyde 
in 0. 1m phosphate buffer to each well (3 x 30 min washes). Fixed cells were washed 
in 0 .1m  phosphate buffer pH 7.4, containing 2% sucrose and 0.02% calcium chloride,
3 x 10 m in), and then stored in 1m sucrose at 4 °C until required for em bedding.
Extracellular matrix consists of the extracellular extract from Engelbreth - Holm - Swarm 
mouse tumour, as described on page 79.
2.4 DNA analysis
2.4.1 Extraction of DNA
Frozen mammary tissue was ground to a powder under liquid nitrogen, and incubated 
for 3 h at 56°C in 10 volumes (w/v) of 10 mM Tris-HCl pH 8.0 containing 1 mM 
EDTA, 0.5% (w/v) SDS and 100 /*g/ml proteinase K. The digest was extracted with 
phenol pH 8.0 (3 x 1 volume) and chloroform:isoamylalcohol (24:1 (v/v), 1 x 1 
volume), incubated with 5 /xg / ml RNase A for 18 h at room temperature and genomic 
DNA was precipitated with ethanol. DNA was resuspended in 10 mM Tris-HCl pH 
8.0 containing 1 mM EDTA, and yield was assayed by A260/28o ratio.
Alternatively, DNA was prepared using a Puregene DNA Isolation Kit, 
(Flowgen, Sittingboume, UK) according to the manufacturers instructions, except that 
frozen mammary tissue was homogenised in liquid nitrogen prior to mixing with the 
cell lysis solution and samples were treated with RNase for 3 h rather than for 15 - 60 
min. When DNA was extracted from frozen cells after culture experiments the cell 
pellets were resuspended in 600 /xl of cell lysis solution and samples were treated with
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In the initial stages of the project, laddering of DNA on agarose gels was detected by ethidium 
bromide staining. The same method had been used in all previous studies of mammary apoptosis 
(refs). This method proved both insensitive and of low reproducibility. Similar conclusions have 
been drawn when this method was used with other tissues (Oberhammer et al., 1992). In many 
samples, visualisation of DNA laddering by ethidium bromide binding required overloading of 
DNA to an extent which exceeded the linear range for ethidium bromide fluorescence. Indeed, 
in several instances where cell death was by other criteria apoptotic, DNA electrophoresis and 
ethidium bromide staining did not detect laddering (Collins et al., 1992; Lockshin et al., 1991; 
Tomei, 1991; Zakeri et al., 1993).
The shortcomings of ethidium bromide staining could not be overcome by varying the conditions 
for gel staining e.g. by increasing DNA loading or ethidium bromide concentration. Thus, 
although laddering (as a proportion of total DNA) could be in theory be quantitated for individual 
samples by densitometry of gels photographed under UV illumination, providing that sample 
loading and staining conditions were optimal, this was not possible in practice. Visualisation of 
oligonucleosomal ladders required DNA overloading to the extent that intact DNA was not 
quantifiable. Moreover, comparison of sequential samples necessitated constant DNA loading 
with the result that, for example, early-involution laddering was undetectable or late involution 
laddering was excessive. Finally, it was found that the method was unreliable. The same samples 
gave markedly differing results when analysed on several occasions. From this we concluded that 
ethidium bromide staining was impracticable for the studies we wished to undertake in mammary 
tissue.
An alternative to ethidium bromide staining for detection of DNA laddering was developed from 
a method used successfully with ovarian tissue (Rosl, 1992). This method depends on nick end- 
labelling of fragmented DNA with [32P]-deoxynucleotide. Nick end-labelling obviated the 
difficulties of sensitivity and reproducibility associated with ethidium bromide labelling. For 
example, DNA laddering was observed reproducibly at peak lactation when ethidium bromide 
staining failed to detect any laddering. Similarly, repeated assay of standard samples under the 
same conditions produced similar results, which were measured by [32P] Cerenkov counting of 
incorporated radiolabel prior to gel electrophoresis and autoradiography, for example a sample 
of DNA from a mid lactation mouse after two days of litter removal gave Cerenkov counts of 
10,520 ±260 cpm / pg DNA. This approach was used to quantitate apoptosis induced after litter 
removal in mice and during endocrine manipulation in rats. Both studies have been accepted for 
publication (Quarrie et al., 1995; Travers et al., 1996).
In adopting nick end labelling as a means of quantifying cell death by apoptosis, some limitations 
to the method must be recognised. The cumulative intensity of signal for the “rungs” in the ladder 
is a measure of oligonucleosomal DNA cleavage, and cannot be directly compared with ethidium 
bromide staining which occurs by intercalation with DNA, and whose intensity is a function of 
both cleavage and length of fragment generated. Thus, the intensity of the lowest rungs of the 
ladder tended to be greatest, this was not the case for ethidium bromide staining. In addition, 
oligonucleosomal fragments will subsequently be cleaved by non-specific endonuclease; and for 
quantitation to be accurate, considerable care must be taken to avoid degradation of DNA during 
analysis.
RNase for 3 h rather than 15 -60  min, otherwise the protocol was followed according 
to the manufacturer’s instructions.
2.4.2 DNA electrophoresis
DNA samples (10 /xg) were subjected to electrophoresis in 1.8% (w/v) agarose gels 
prepared in 40 mM Tris-HCl (pH 8.2) containing 20 mM sodium acetate, 1 mM EDTA 
and 5 /xg/ml ethidium bromide, and photographed under UV illumination.
2.4.3 End labelling of DNA
DNA (10 /xg) was diluted with an equal volume of 100 mM Tris-HCl pH 8.0 containing
10 mM MgCl2 in a siliconised microcentrifuge tube, and incubated with 30 nCi of
a[32P]-dCTP and 2.5 U of DNA polymerase 1 (Klenow fragment) for 10 min at room
temperature. The reaction was stopped by addition of EDTA (final concentration, 10
mM), and the reaction volum e was adjusted to 100 /xl with water. DNA was recovered
by ethanol precipitation in the presence of 20 /xg glycogen, and resuspended overnight
in 10 mM Tris-HCl pH 8.0 containing 1 mM EDTA. Incorporation of a [32P]-dCTP
radioactivity into samples was determined using a liquid scintillation analyzer 1600 Tr
(Canberra Packard, Pangbourne, UK). DNA samples (1 /xg) were subjected to
agarose gel electrophoresis as described above. Equal loading of DNA was confirmed
by UV illumination before the gel was fixed in 7 % (w/v) trichloroacetic acid for 20
min. The gel was dried, sealed in plastic and subjected to autoradiography at -80 C. 
This method is a modification of a method described by Rosl (1992).
Refer to text explaining limitations of this method inserted on page 37
2.4.4 DNA assay
DNA was measured by a fluorometric procedure (Labarca and Paigen, 1980). The
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DNA standard (calf thymus) was prepared in water at 1 mg/ml at 4°C, and diluted to 
10 /xg/ml with assay buffer (0.1 M NaH2P 04, pH 7.4 containing 2 M NaCl) before use. 
Fluorescent reagent was prepared by dissolving bisbenzimide (Fluka, Glossop, UK) in 
water at 1 mg/ml and diluted to 3 /xg/ml with assay buffer before use.
Tissue samples were sonicated (15 s at setting 30; Kontes micro-ultrasonic cell 
disruptor, (Burkard Scientific, Middlesex, UK) in assay buffer and an appropriate 
volume was removed for assay. The DNA standard was used in the range 0 - 4 /xg and 
all assay volumes were made up to 1ml with assay buffer before addition of 0.5 ml of 
fluorescent reagent. After 15-20 min at room temperature, fluorescence was measured 
in a DNA TKO 100 minifluorimeter (Hoeffer Instruments, San Francisco, USA).
2.5 Histology
2.5.1 Tissue collection
Female mice and rats were killed by cervical dislocation. Mammary tissue was 
removed immediately and portions were snap-frozen in liquid nitrogen or fixed in 
freshly prepared 4% (w/v) paraformaldehyde in 0.1m phosphate buffer pH 7.4 for 1 
h. Fixed tissue was then transferred into 0. 1m phosphate buffer pH 7.4 for subsequent 
histological analysis.
2.5.2 Histological analysis
Fixed tissues were dehydrated through graded alcohols and chloroform, and paraffin 
embedded. Sections (4 /xm) were cut on a Reichert-Jung Autocut 2040 microtome and 
attatched to poly-L-lysine subbed slides. Paraffin wax was removed from the sections
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by incubating at 56°C for 30 min before immersing in xylene or Histoclear (Agar 
Scientific, Stansted, UK). Thereafter, sections were taken through graded alcohols to 
water so that staining could commence.
Fixed cells from culture experiments were scraped from the tissue culture plate 
with a spatula and transferred to a 1.5 ml microcentrifuge tube with a wide bore 
pipette. The cells were pelleted (80 g , 5 min, room temp) and the supernatant was 
removed. The pellet was gently resuspended in OCT freezing compound over 5 min 
to form a capsule of cells and OCT. This capsule was lowered into liquid nitrogen, 
the microcentrifuge tube coating was removed and the capsule was embedded onto the 
cryostat chuck at -80°C. Frozen sections (5 /xm) were cut and air-dried for 24 h before 
staining.
For examination of tissue morphology, sections were stained with Meyer’s 
haematoxylin (20 min, room temperature), followed by "blueing up" in warm tap water 
(5 min) and staining in eosin (1 min, room temperature). Sections were then rinsed in 
water, dehydrated through graded alcohols and xylene, before mounting in DPX (Agar 
Scientific, Stansted, UK)
For inspection of chromatin, sections were stained in diamidinophenylindole 
(DAPI; 1 ng/ml) for 5 min, rinsed in water and mounted in Vectashield (Vector 
laboratories, Peterborough, UK).
Milk protein production was investigated by staining with fluorescently- 
labelled polyclonal antisera raised in-house against total casein, J3 casein, whey acidic 
protein and transferrin. After 2 h of antibody staining, sections were rinsed in water 
and mounted in Vectasheild (Vector laboratories, Peterborough, UK).
Distribution o f  laminin in tissue sections, was determined with an anti-laminin
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mouse antibody (TCS biologicals, Botolph Claydon, U.K.), followed by a rabbit anti mouse 
biotinylated second antibody and finally visualised using an avidin biotin complex (ABC) 
Horse radish peroxidase was linked to the avidin-biotin in the ABC complex
kit (Dako, High Wycombe, UK) at room temperature for 30 min and followed by 0.6
mg/ml diaminobenzidine for 2-5 minutes. Sections were then rinsed in water,
dehydrated through graded alcohols and xylene, before mounting in DPX (Agar
Scientific, Stansted, UK).
2.5.3 In situ end labelling of DNA
Sections were digested with 0.5% (w/v) pepsin at ambient temperature for 15 min, and 
end labelled using ImM biotinylated deoxyuridine triphosphate and 1 U/ml DNA 
polymerase I (Klenow) at 37°C for 30 min as described by Ansari et al., (1993). In 
some cases pepsin treatment was replaced by 50 /xg/ml proteinase K at 37° C for 15 
min. Endogenous peroxidases were inactivated by incubating sections with 3% (v/v) 
hydrogen peroxide at room temperature for 15 min. End labelling was then revealed 
by sequential incubation with the ABC kit (Dako, High Wycombe, UK) at room 
temperature for 30 min, and 0.6 mg/ml diaminobenzidine. Sections were 
counterstained with Meyer’s haematoxylin, dehydrated and then mounted in DPX.
2.6 RNA studies
2.6.1 RNA extraction
RNA was prepared by the method of Chirgwin et al., (1979). Frozen mammary tissue 
(0.01 - 0.05 g tissue)
was ground to a powder under liquid nitrogen, and vortexed in 3.5 ml of RNase 
inhibiting buffer (0.05 M Tris-HCl pH 7.5, 0.01 M EDTA pH 7.5 containing 4.22 M 
guanidium thiocyanate, 5% Sarkosyl and 1% 2-mercaptoethanol). DNA was sheared
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by passing the homogenate through 21G and then 23G needles, and caesium chloride 
(1.4 g) was added. This was then layered above a 1.5 ml caesium chloride cushion 
(5.7 M caesium chloride pH 7.5, 0.1 M EDTA) and centrifuged (149,000 g , 20°C, 17 
h). The RNA pellet was resuspended in water in a sterile tube and impurities were 
removed by chloroform:butanol (4:1, 2 x 1 volume). RNA was precipitated with 
ethanol, resuspended in water and assayed by A260/28o ratio.
Alternatively, RNA was prepared using the Ultraspec II RNA isolation system 
(AMS Biotechnology Ltd., Witney, Oxon, UK). Frozen tissue samples were ground 
in liquid nitrogen before adding to the Ultraspec RNA reagent. Frozen cell pellets 
were mixed with the Ultraspec RNA reagent. The manufacturer’s protocol was then 
followed exactly. RNA was resuspended in water and assayed by A260/28o ratio.
2.6.2 RNA electrophoresis
RNA samples (5 /xg or 40 /xg) were loaded onto a 1.2% agarose gel prepared in 20 mM 
MOPS pH 8.0 containing 1 mM EDTA pH 8.0, 8 mM sodium acetate, 1.85% (w/v) 
formaldehyde and 0.5 /xg/ml ethidium bromide. Samples were subjected to 
electrophoresis at 60 V for approximately 2 h. The gel was photographed under UV 
illumination to confirm equal loading of samples, and then was washed in 10 x SSC 
[1 x SSC is 0.15 M sodium chloride pH 7.0, 0.015 M sodium citrate pH 7.0). RNA 
was transferred overnight to Biotrans nylon membrane (ICN Flow, Irvine, UK) and 
was firmly attached to the membrane by UV crosslinking (Spectrolinker XL-1000, 
Spectronics Corporation, New York, USA). The membrane was then wrapped in 
plastic and stored at 4°C.
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2.6.3 Preparation of cDNA probes
Plasmids containing cDNA inserts (1-10 ng) encoding mRNAs of interest were 
transformed into E.coli JM109 cells by standard procedures (Hanahan et al., 1985). 
Tranformants were plated on agar plates containing 25 /xg/ml ampicillin. After 
overnight incubation at 37°C, colonies growing on the agar were selected and grown 
in 50 ml of LB broth (10 g bacto-tryptone, 5 g bacto yeast extract, 10 g NaCl per litre 
of water, pH 7 .0 ) .  Plasmid DNA was then extracted from the cells by alkaline lysis 
(10 mM sodium hydroxide followed by 3 M potassium acetate) following the method 
of Sambrook et al., (1989). DNA was treated with RNase (20 /xg/ml, 37°C, 1 h), and 
2 /xl was resolved on a 1 % (w/v) agarose gel in 0.05 M Tris pH 7 .5  containing 0.05m  
boric acid, 1 mM EDTA and 5 /xg/ml ethidium bromide for 2 h at 70  V, to ensure 
intact, high quality plasmid had been isolated.
Insert DNA was digested from vector DNA with restriction enzymes according 
to the restriction sites present on the vector and insert (Table 2.1).
cDNA Vector Insert Restriction enzymes to isolate insert
Stromelysin pBR322 1.5-1.6 kb EcoRl
TIMP-2 pSP73 0.8 kb Hind 111 and BGL 11
p53 pGem 1.3 kb EcoRl
Table 2.1 Preparation of cDNA probes. Information essential for ensuring the 
correct cDNA probe is isolated for northern blotting.
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After overnight incubation, at 37°C, of DNA with a restriction enzyme, the 
DNA was ethanol precipitated and resuspended in water. DNA was resolved on a 1 % 
(w/v) low melting point agarose gel (Gibco BRL, Paisley, UK) in 40 mM Tris-acetate 
(pH 8.2), 1 mM EDTA and 0.5 /xg/ml ethidium bromide, and photographed under UV 
illumination.
The insert was excised from the gel, placed in a microcentrifuge tube and 3 
ml of water was added for every gram of gel. The mixture was boiled for 10 min and 
then stored at -20°C.
On the day of use the cDNA probe was boiled for 3 min and 12.5 ng was 
incubated in a labelling reaction, containing 2.5 /xl of OLB, 0.5 /xl of 10 mg/ml BSA,
12.5 /xCi of a[32P]-dCTP and 2U of DNA polymerase I (Klenow), to a total reaction 
volume of 25 /xl, for 2.5 h at room temperature (Feinberg and Vogelstein, 1984).
Radiolabelled DNA was separated from unincorporated label on a 2 ml G50 
Sephadex column. The a[32P]-dCTP activity of DNA was counted on a liquid 
scintillation analyzer 1600TR (Canberra Packard, Pangboume, UK), and the DNA was 
precipitated, then resuspended in 50 /xl of water and stored at -20°C for up to one 
week.
2.6.4 Northern blotting with cDNA probes
Filters were pre-hybridised (42°C for 4 h, 2 h on each side) in hybridisation buffer 
(50% (v/v) deionised formamide, 5 x SSC, 200 /xg/ml salmon sperm DNA, 0.1 % (w/v) 
lauryl sulphate, 5 x Denhardts solution and 0.05% (v/v) pyrophosphate tetrasodium) 
using a hybridisation oven (Appligene, Newcastle, UK ). The radiolabelled cDNA 
probe was boiled for 10 min and then added to the hybridisation tube in 10 ml of fresh
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hybridisation buffer for 18 h.
Filters were removed from the hybridisation oven and washed on a shaking 
platform (3 x 100 ml; 10 min room temperature in 2 x SSC pH 7.0, containing 0.1% 
(w/v) lauryl sulphate), followed by washing in a pre-heated waterbath (1 x 100 ml of 
0.2 x SSC pH 7.0, containing 0.1 % (w/v) lauryl sulphate), at increasing 10°C intervals 
until only hybridised probe remained on the filter. At this point the filter was sealed 
in plastic and subjected to autoradiography.
2.6.5 Design of oligonucleotides
Cross-species 30-mer oligonucleotide probes for bcl-2 and box were designed from 
accession sequences for bcl-2 and box mouse, rat and human gene sequences using 
computer programs.
Oligonucleotides were identified and designed using the Blast Gateway to USA computer 
programme.
Bcl-2 oligonucleotide sequence corresponded to 434 - 463 bp (Tsujimoto and Croce, 
1986) 3’ CCTCCTAACACCGGAAGAAACTCAAGCCAC 5’
Bax oligonucleotide sequence corresponded to 174 - 203 bp (Oltvai et al., 1994)
3’ CTACGCAGGTGGTTCTTCGACTCGTTCTGT 5’
Bax GenBank accession numbers were:- human bax - L22473.gb-pr, L22474.gb-pr, 
L22475.gb-pr, murine bax - L22472.gb-ro, rat bax - L22471.gb-ro, human bcl-2- 
L15048.gb-pr, murine bcl-2 - L 15047.gb-ro, rat bcl-2 - L15049.gb-ro.
2.6.6 Northern blotting with oligonucleotide probes
Oligonucleotide 30-mer sequences (10 fig) were labelled with 1 /xCi of [32P]-dATP, 
using 0.008 U of T4 polynucleotide kinase (37°C, 30 min). Unincorporated label 
was separated from labelled DNA using a 2 ml column. The [32P]-dATP activity of
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labelled DNA was counted on a Liquid Scintillation Analyzer 1600 TR (Canberra 
Packard, Pangbourne, UK) and DNA was ethanol precipitated, resuspended in 50 /j l \ 
of water and stored at -20 °C for up to one week.
Filters were prehybridised for 4 h (2 h each side) in 10 ml of hybridisation 
buffer (6 x SSC, 5 x Denhardts, 0.1% (w/v) lauryl sulphate, 0.05% (v/v) 
pyrophosphate tetrasodium and 200 jug/ml salmon sperm DNA) in the hybridisation 
oven. Radiolabelled oligonucleotide probes were added to the hybridisation tube in 10 
ml of fresh hybridisation buffer for 18 h.
Filters were removed from the hybridisation oven and washed on a shaking 
platform (3 x 100 ml washes in 6 x SSC pH 7.0 containing 0.1% (w/v) lauryl sulphate 
for 10 min, at room temperature), followed by washing in a pre-heated waterbath (1 
x 100 ml of 6 x SSC pH 7.0 containing 0.1 % (w/v) lauryl sulphate for 30 min) at Tm - 
12 °C. At this point the filter was sealed in plastic and subjected to autoradiography.
2.6.7 Densitometry
RNA from at least three animals at each time-point was electrophoresed under 
denaturing conditions. This RNA was visualised by ethidium bromide staining and 
photographed, the relative amounts of 28S RNA loaded onto each lane on the gel were 
determined using a video densitometer (Biorad, UK). The densitometer scanned each 
lane at least three times and an average value was obtained. Autoradiographs, depicting 
expression patterns of various cDNA probes were also scanned by the densitometer, 
each lane on the autoradiographs was scanned at least three times in the area of interest 
for each probe. The whole track area was also scanned on autoradiographs containing
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bax or T1MP-2 expression data, since expression of more than one transcript was 
revealed by northern analysis. The average value of expression obtained for each lane 
as normalised according to RNA loading. The yield of RNA /g tissue, which had been 
noted during extraction of RNA, varied considerably between lactating tissue, where 
RNA yield was approximately 10.9mg/g tissue, and involuting tissue, where RNA 
yield could be as low as 2.(mg 'g tissue. Therefore normalised RNA expression values 
were expressed per unit RNA to take into account differences in tissue RNA levels. 
This method elimimates the requirement for an internal control or housekeeping gene.
Day to day control of RNA blots was achieved by including the same two control 
samples of RNA on each RNA gel. The controls comprised one sample of RNA from 
lactating mouse mammary gland and one sample of RNA from involuting mouse 
mammary gland. Expression levels from one blot to the next can then be normalised 
according to the level of expression from the two control samples, after expression 
was corrected for variations in RNA loadings.
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CHAPTER THREE 
APOPTOSIS IN MOUSE MAMMARY TISSUE
3.1 Introduction
It is now well established that cell removal during mammary involution is by 
programmed cell death i.e. apoptosis (Walker et al., 1989; Strange et al., 1992; 
Tenniswood et al., 1992; Atwood et al., 1995). The progression of apoptosis during 
involution was followed by light and electron microscopy (Walker et al 1989), while 
changes in an extensive range of genes expressed during the involution process have 
been compared with the progression of apoptosis in mouse mammary tissue, to discover 
some of the important genetic changes that regulate mouse mammary apoptosis (Strange 
et al., 1992, Tenniswood et al., 1992). Throughout these studies DNA laddering was 
visualised by ethidium bromide staining of electrophoresed DNA (Walker et al., 1989, 
Strange et al., 1992).
In all of these studies mammary apoptosis has been studied primarily in mouse 
mammary tissue after litter removal in peak lactation, a somewhat unnatural in vivo 
situation. To date, apoptosis induced at other timepoints in the lactation cycle, by 
mechanisms other than litter removal, has received very little attention. This study has 
examined the time course and extent of apoptosis induced by litter removal in declining 
lactation and during natural weaning, conditions which represent more natural 
manipulations of the involution process. The processes of natural weaning have been
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studied in both non pregnant and pregnant mice, since there is little or no time between 
successive lactation cycles in vivo. The effect of unilateral milk stasis on mammary 
apoptosis was also investigated to determine if apoptosis could be regulated by local 
control mechanisms sensitive to milk stasis, which may also, at least in part, mediate 
apoptosis after litter removal or during natural weaning.
3.2 Experimental protocol
The timecourse and extent of apoptosis were studied in four experimental situations.
3.2.1 Litter removal
The effects of pup removed were investigated by removing the litter at either peak 
lactation (day 10 of lactation) or in declining lactation (day 16 of lactation).
3.2.2 Natural weaning
The response to litter removal was compared with natural weaning. In this case the 
litter remained with the mother as it was weaned onto solid food, a process which 
began around day 16 of lactation. Tissue was collected on alternate days, for 10 days 
throughout the natural weaning process.
3.2.3 Natural weaning in concurrently pregnant mice
Natural weaning was studied first in non-pregnant mice. However, in other 
circumstances mice are often concurrently pregnant while lactating, with little 
intervening dry period between lactations. We wished to determine if in these
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circumstances, involution and apoptosis was necessary.
3.3.4 Milk stasis
The fourth group of mice was subjected to unilateral teat sealing, such that milk stasis 
was induced in mammary glands on one body half. This technique provides a means 
of assessing the importance of local i.e. intra-mammary mechanisms in regulating 
mammary apoptosis.
3.3 Results
3.3.1 Litter removal at mid-lactation
Induction of apoptosis by litter removal in mid-lactation was accompanied by extensive 
changes in tissue morphology (Fig 3.1) such that 3 - 4 days after litter removal there 
was little evidence of alveolar organisation. Oligonucleosomal DNA laddering 
indicative of apoptosis was detected by ethidium bromide staining after 4 days of litter 
removal (Fig 3.2A). However, when genomic DNA was end-labelled with [32P] dCTP, 
autoradiography revealed increasingly intense DNA laddering in tissue taken 1 or 2 
days after pup removal with a further increase by four days of pup removal (Fig 3.2B). 
After 6 days of litter removal DNA laddering had decreased. Cerenkov counting of 
[32P] dCTP incorporation prior to electrophoresis showed a progressive increase up to 
4 days of litter removal (Table 1), consistent with the intensity of laddering. End- 
labelling of DNA with [32P] dCTP also detected laddering on day 10 of lactation 
suggesting that apoptosis occurs at peak lactation (Fig 3.3). Large DNA fragments 
were also detected after radiolabelling DNA, this may represent intermediates generated 
in endonuclease cleavage prior to internucleosomal fragmentation (Brown et al., 1993;
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Haematoxylin / eosin DAPI
Litter removal 
(days)
Fig. 3.1 Histology of mouse mammary tissue after litter removal in mid- 
lactation. Tissue was collected post mortem immediately and 1,2 or 4 days 
after litter removal on day 10 of lactation. Tissue sections were stained with 
haematoxylin / eosin or DAPI. Bar =  40 pm.
Days of litter removal 
0 1 2  4 6
A
0 1
B | C
Fig. 3.2 DNA laddering in mouse mammary tissue after litter removal in 
mid-lactation. Tissue was collected post mortem immediately and 1, 2, 4 or 
6 days after litter removal on day 10 of lactation. A, ethidium bromide 
staining of resolved DNA. B, ethidium bromide staining of unresolved DNA 
in sample wells confirming equal loading of samples. C, autoradiography of 
[32P] dCTP end-labelled DNA. Results from two animals are shown at each 
timepoint.
Litter removal [32P] incorporated
(days) (CPM/jug DNA 10'3)
0 4.51 ± 0 .1 0
1 9 .0 4 ± 0.61 ***
2 10.73 ± 2.61 Hofc* a
4 13.28 ± 2 .0 3 jft5fS5l< a
6 11.43 ± 0 .7 6 b
Table 3.1 Quantitative analysis of DNA laddering in mouse mammary 
tissue. Tissue was collected post mortem immediately and 1,2,4 or 6 days 
after litter removal in mid-lactation. DNA was nick end-labelled with [32P] 
dCTP using Klenow polymerase and counted for radioactivity (Cerenkov). 
Values are mean +  SEM for 4 animals, except a, n=3. *** P < 0.001 
compared with day 10 values. b, P<0.05 compared with 1 days litter 
removal. Statistical analysis by Student’s t-test.
Fig. 3.3 DNA laddering in mouse mammary tissue at mid-lactation.
Tissue obtained post mortem from two day-10 lactating mice (a and b). DNA 
was extracted from the tissue, end labelled with [ 32P] dCTP and subjected to 
autoradiography.
Oberhammer et al., 1993)
3.3.2 Litter removal during declining lactation.
Although similar histological changes occur following litter removal on day 16 and day 
10 of lactation, tissue involution progressed more rapidly after litter removal on day 
16 of lactation than that on day 10 of lactation. After 2 days, alveolar integrity was 
lost and luminal spaces had filled with intact cells and apoptotic bodies (Fig 3.4). At 
this stage DNA content had decreased by 35% compared with day 16, and six days 
after litter removal, total DNA content was 36% of the pre-treatment value.
The change in DNA laddering after litter removal on day 16 was similar in 
time course to that induced at peak lactation. Laddering increased on the first day of 
litter removal, increased further on the second day, remained high on day 4 and 
decreased after 6 days (Fig 3.5). However laddering was consistently more intense 
than that observed after litter removal on day 10.
The method for end-labelling DNA with [32P] dCTP was optimised using tissue 
from which the litter was removed in declining lactation. More [32P] dCTP was 
incorporated into DNA with DNA polymerase 1 (Klenow) than with terminal 
transferase (Fig 3.6A). Precipitation of DNA end-labelled with [32P] dCTP recovered 
more labelled DNA than using a spin column (Fig 3.6B), and glycogen produced a 
higher recovery of DNA after precipitation. dNTP’s in the reaction mix did not 
influence the extent of radiolabel incorporated into DNA (Fig 3.6C).
Fragmented DNA was demonstrated in tissue sections by addition of a dUTP 
to the ends of fragmented DNA. From this technique fragmented DNA was 
end-labelled and visualised in situ (ISEL). Prostate and thyroid gland tissue were used
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Litter removal 
(days)
0
Fig. 3.4 Histology of mouse mammary tissue after litter removal in 
declining lactation. Tissue was collected post mortem immediately and 2,4 
or 6 days of litter removal on day 16 of lactation. Tissue sections were 
stained with DAPI. Arrows, apoptotic bodies. Bar =  40 pm.
Days after litter removal
0 1 2  4 6
0 1 2  4 6
Fig. 3.5 DNA laddering in mouse mammary tissue after litter removal in 
declining lactation. Tissue was collected post mortem immediately and 1,2,4 
or 6 days after litter removal on day 16 of lactation. A, ethidium bromide 
staining of resolved DNA. B, ethidium bromide staining of unresolved DNA 
in sample wells to confirm equal loading of samples. C, autoradiography of 
[32P] dCTP end-labelled DNA. Results from two animals are shown at each 
timepoint.
Duration of autoradiography 
2 days 1 week
K T K T
B C
S E D + D- G + G- D +G  +
Fig. 3.6 Optimisation of nick end-labelling for visualisation of DNA 
ladders in mouse mammary tissue. A, Autoradiography of DNA nick end- 
labelled with [32P] dCTP using either Klenow polymerase (K) or terminal 
transferase (T). B, Autoradiography of DNA nick end-labelled with [32P] 
dCTP and Klenow polymerase. Labelled DNA was recovered by either 
ethanol precipitation (E) or a spin column (S). C, Autoradiography of DNA 
nick end-labelled with [32P] dCTP and Klenow polymerase with and without 
dATP, dTTP and dGTP (D) included in the reaction mix, and with or without 
glycogen (G) included in the precipitation.
as positive controls and displayed the expected proportion of positively stained cells (B.
Ansari, personal communication). Staining was specific since omission of the
antibody or the avidin-biotin procedure resulted in no positively stained cells (Fig 3.7).
The staining pattern in mammary tissue after litter removal on day 10 of lactation is
shown in Fig 3.8. Nuclei containing fragmented DNA were detected 2 days into the
involution process and the number of fragmented nuclei increased further by 4 days of
involution. ISEL-positive mammary cells were distributed, apparently at random,
through the epithelium. There was no evidence of coordinated apoptosis, either at an
alveolar or whole gland level.
Litter removal in peak or declining lactation was associated with changes in
the expression of two genes implicated in the regulation of programmed cell death.
p53 mRNA, undetectable prior to litter removal, was induced within 1 day of litter
Table 3.2
removal in declining lactation, and remained high for at least 4 days (Figs 3 .9-3 .11).
Bax whose gene product is reported to form homodimers and stimulate apoptosis
(Oltvai et al. 1993), was expressed in the early stages of litter removal in declining
Table 3.2
lactation, but expression decreased markedly after 2 days (Figs 3.9 - 3.11). It 
appeared that the bax oligonucleotide may detect several mRNA transcripts. Therefore 
densitometry was performed on both the whole area exposed to northern analysis and 
just to the area that had previously been reported to represent bax expression. Both 
analyses showed proportionately similar changes, and all the values relating to bax 
expression in this chapter are those refering to the previously reported area of bax 
expression. The detection of several mRNA species by the bax oligonucleotide is 
unlikely to represent non-specific hybridisation due to the high stringency of post 
hybridisation washes, but maybe the bax oligonucleotide is detecting other perhaps as
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AB
C
Fig. 3.7 In situ end-labelling (ISEL) of mouse mammary tissue sections 
with biotinylated dUTP. A, mouse mammary tissue section treated with 
DNase 1 prior to application of dUTP antibody. B, negative control, omitted 
avidin-biotin from the staining procedure. C, mouse thymus tissue section 
containing a proportion of apoptotic cells (sections courtesy of Dr. B Ansari). 
Arrows, cells containing fragmented DNA.
A B
Litter removal 
(days)
Tissue Percentage of ISEL positive cells
lactating tissue <0.2%
2-3 days of litter removal 1.7%
4 days of litter removal 4.5%
Fig. 3.8 In situ end labelling (ISEL) of mouse mammary tissue sections.
Tissue was collected post mortem immediately and 1, 2 or 4 days after litter 
removal on day 10 of lactation. Arrows, cells containing fragmented DNA. 
A, Bar = 40 pm. B, Bar = 5 pm.
Fig. 3.9 Mouse mammary gene expression after litter removal on 
day 10 of lactation. Expression of p53, box, stromelysin and TIMP-2 
was measured by northern analysis of total RNA. A, ethidium 
bromide staining of total RNA after agarose gel electrophoresis. B, 
northern analysis of RNA hybridised with [32P] dCTP end-labelled 
cDNA probes. C, densitometry of hybridised RNA detected by 
autoradiography and corrected for RNA loading and RNA yield/g 
tissue. Values are the mean ±  S.E.M. for 3 animals. Arrows indicate 
18S ribosomal RNA.
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Fig. 3.10 Mouse mammary gene expression after litter removal on 
day 16 of lactation. Expression of p53, box, stromelysin and TIMP-2 
was measured by northern analysis of total RNA. A, ethidium 
bromide staining of total RNA after agarose gel electrophoresis. B, 
northern analysis of RNA hybridised with [32P] dCTP end-labelled 
cDNA probes. C, densitometry of hybridised RNA detected by 
autoradiography and corrected for RNA loading and RNA yield/g 
tissue. Values are the mean ±  S.E.M. for 3 animals. Arrows indicate 
18S ribosomal RNA.
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Fig. 3.11 Comparision of mammary gene expression after litter removal
on day 10 or day 16 of lactation. mRNA abundance was measured in tissue 
extracts by northern blotting and densitometry using [32P]-labelled cDNA 
probes. Open bars, litter removal on day 10 of lactation. Filled bars, litter 
removal on day 16 of lactation. Results are corrected for RNA loading and 
RNA yield/g tissue and expressed in arbitrary units. Values are the mean ±  
S.E.M. for 3 animals.
expression was induced more rapidly in late lactation. In all cases yields of RNA were 
normalised by densitometry to correct for differences in RNA gel loading. The amount 
of RNA per unit weight of tissue falls dramatically during tissue involution and so 
expression of message was also corrected to take this into account.
Bax is also reported to form heterodimers with the bcl-2 gene product and 
antagonise its ability to inhibit apoptosis (Oltvai et al., 1993). Expression data relating 
to bax is difficult to interpret since the proportion of homodimeric and heterodimeric 
bax expression is unknown at any given timepoint. Bcl-2 gene expression was not 
detected in mouse mammary tissue by northern analysis at any stage before or after 
litter removal. Two oligonucleotides constructed from a published mouse sequence of 
the bcl-2 gene failed to hybridise with lactating or involuting mouse mammary RNA, 
as did a cDNA probe previously shown to detect bcl-2 expression in a range of mouse 
tissues, but not mammary gland (Boise et al., 1993). Different hybridisation 
temperatures and washing conditions also failed to yield a positive result but in each 
attempt bcl-2 message was not detected in lactating or involuting mouse mammary 
tissue. However, bcl-2 message was also not detected in adult mouse spleen, a tissue 
previously reported to show expression of bcl-2, and this suggests that none of the 
hybridisation conditions tried may have been optimal, despite having tried several 
different hybridisation temperatures, since expression was not detected with 
oligonucleotide or cDNA probes.
Tissue remodelling during mammary involution is the result of concerted 
changes in proteases and their inhibitors (Talhouk et al., 1991, 1992). These events 
were monitored by northern blot measurement of stromelysin mRNA, a major protease 
in involuting mouse mammary tissue (Talhouk et al., 1991), and that of its inhibitor,
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were monitored by northern blot measurement of stromelysin mRNA, a major protease
in involuting mouse mammary tissue (Talhouk et al., 1991), and that of its inhibitor,
TIMP-2 (Docherty et al. 1985). Stromelysin RNA was undetectable in lactating tissue
but increased thereafter. TIMP-2 was detected as a major band and several larger and
Table 3.2
smaller transcripts, (Figs 3.9 - 3.11) as reported previously (Gewert et al., 1987).
Analysis of either the 800 bp band alone or the whole area exposed to the TIMP-2
cDNA probe showed proportionately similar changes. In this chapter all values of
TIMP-2 expression refer to densitometry of the single 800 bp band. It was expressed
at a relatively high level on day 16 of lactation and one day after litter removal, but
Table 3.2
decreased thereafter (Figs 3.9 - 3.11). This suggests maximum proteolytic activity 
after one day of litter removal on day 16 of lactation. Stromelysin expression was also 
induced rapidly by litter removal on day 10, but in this case, TIMP expression 
remained high on the second day of litter removal, and it was not until after 2 days of 
litter removal that the balance of protease to inhibitor appeared to favour degradation. 
Therefore, the pattern of protease and protease inhibitor expression suggested that 
proteolysis was induced more rapidly by litter removal in late lactation.
3.3.3. Natural weaning
In mice, natural weaning of the litter begins around day 16 of lactation. As a result, 
milk yield decreased from 13.8 + 1.3 g/day on day 16 of lactation to 0.7+0.3 on day 
20, as the young became accustomed to solid food (Shipman et al., 1987). Weaning 
was accompanied by progressive loss of tissue organisation similar to, but slower than 
that observed after litter removal. On day 18, the alveoli remained intact, but by day 
20 epithelial integrity was lost and alveoli had collapsed, with widespread evidence of
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nuclear karyohexis (Fig 3.12).
Morphological degeneration was accompanied by mammary cell loss and an 
increase in DNA laddering, indicating that, as with litter removal, apoptotic death 
contributes to tissue involution during natural weaning (Fig 3.13). Laddering was 
detectable on day 16 - 18 at a level comparable to that observed in day 10-lactating 
mammary tissue. This increased on day 18-20, and on day 22 of lactation, despite the 
continuing presence of the litter, laddering had increased to a level similar to that 
observed after litter removal. Accordingly, tissue DNA content was unchanged on day 
18, but lower by 23% and 50% than day 16 values on days 20 and 22 respectively. 
Programmed cell death appeared to be largely complete by day 24. At this stage DNA 
laddering was barely detectable (Fig 3.13), and tissue DNA content was 30% of that 
on day 16.
Degenerative changes in tissue morphology were associated with a progressive
decline in TIMP-2 expression and, on day 22, induction of stromelysin mRNA, which
Table 3.2
had been undetectable by northern analysis up to this time (Figs 3 .14-3 .15). A high
level of apoptosis on day 22 coincided with induction of p53 mRNA, and a high level
Table 3.2
of box gene transcripts (Figs 3.14 - 3.15).
Mammary involution in mice concurrently pregnant while weaning their litters
differed markedly with respect to tissue morphology (Fig 3.16), time course of
programmed cell death (Fig 3.17) and pattern of gene expression from that in non-
Table 3.2
pregnant animals (Figs 3.18 - 3.19). Loss of alveolar integrity was apparent on day 
18 of lactation and well advanced by day 20, at which stage involution in concurrently 
pregnant animals resembled that induced by litter removal more than the gradual 
changes induced by natural weaning in non-pregnant animals. On day 22, i.e. day 1
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Day of lactation
Fig 3.12 Histology of mouse mammary tissue during natural weaning.
Tissue was collected post mortem on day 16, 18, 20 and 22 of lactation. 
Tissue sections were stained with DAPI. Bar = 40 fim.
Day of lactation
B
1256-
Fig. 3.13 DNA laddering in mouse mammary tissue during natural 
weaning. Tissue was collected post mortem on days 16, 18, 20, 22 and 24 
of lactation. Duplicate samples are shown. A, ethidium bromide staining of 
resolved DNA. B, ethidium bromide staining of unresolved DNA in sample 
wells to confirm loading of samples. C, autoradiography of [32P] dCTP end- 
labelled DNA. Results from two animals are shown at each timepoint.
A, 10 g DNA loaded. B, 1 g DNA loaded.
D, relative position of molecular weight markers with respect to electrophoresed DNA.
/ .
Fig. 3.14 Mouse mammary gene expression during natural 
weaning. Expression of p53, bax, stromelysin and TIMP-2 was 
measured by northern analysis of total RNA. A, ethidium bromide 
staining of total RNA after agarose gel electrophoresis. B, northern 
analysis of RNA hybridised with [32P] dCTP end-labelled cDNA 
probes. C, densitometry of hybridised RNA detected by 
autoradiography and corrected for RNA loading and RNA yield/g 
tissue. Values are the mean ±  S.E.M. for 3 animals. Arrows indicate 
18S RNA.
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Fig. 3.15 Comparision of mouse mammary gene expression during 
natural weaning and after litter removal. mRNA abundance was measured 
in tissue extracts by northern blotting and densitometry using [32P] dCTP end- 
labelled cDNA probes. Open bars, with pup removal. Hatched bars, without 
pup removal. Results are corrected for RNA yield/g tissue and expressed in 
arbitrary units. Values are the mean ±  S.E.M. for 3 animals.
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Fig. 3.16 Histology of mouse mammary tissue during natural weaning in 
non-pregnant and pregnant mice. Tissue was collected post mortem on days 
20, 22 and 26 of lactation. A, non pregnant mice. B, concurrently pregnant 
mice; day of second lactation in parentheses. C, first pregnancy and early 
lactation controls^; day of lactation in parentheses. Bar =  40 /im. 
Haemotoxylin and eosin staining.
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Fig. 3.17 DNA laddering during natural weaning in concurrently 
pregnant mice. Tissue was collected post mortem on day 16, 18, 20, 22 or 
24 of the first lactation. Re-mated mice littered on day 21 of lactation. A, 
ethidium bromide staining of resolved DNA. B, ethidium bromide staining 
of unresolved DNA in sample wells to confirm equal loading of samples. C, 
autoradiography of [32P] dCTP end-labelled DNA. Results from two aminals 
are shown at each timepoint.
Fig. 3.18 Mammary gene expression during weaning in 
concurrently pregnant mice. Expression of p53, bax, stromelysin 
and TIMP-2 was measured by northern analysis of total RNA. A, 
ethidium bromide staining of total RNA after agarose gel 
electrophoresis. B, northern analysis of RNA hybridised with [32P] 
dCTP end-labelled cDNA probes. C, densitometry of hybridised 
RNA detected by autoradiography and corrected for RNA loading and 
RNA yield/g tissue. Values are the mean ±  S.E.M. for 3 animals. 
Arrows indicate 18S ribosomal RNA.
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Fig. 3.19 Comparision of mouse mammary gene expression during 
natural weaning in non-pregnant and pregnant mice. mRNA abundance 
was measured in tissue extracts by northern blotting and densitometry using 
[32P]-labelled cDNA probes. Open bars, non pregnant mice. Filled bars, 
remated mice. Results are corrected for RNA yield / g tissue and expressed 
in arbitrary units. Values are the mean +  S.E.M. for 3 animals.
of the second lactation, the glands of concurrently pregnant mice still showed little 
evidence of alveolar structure, and epithelial cell nuclei and total cell volume remained 
small compared with fully differentiated, lactating cells (Fig 3.16). Thus, the tissue 
resembled neither that in late involution, nor that of early lactating tissue, in which 
alveoli were intact and distended with accumulated milk. However, by day 5 of the 
second lactation, mammary tissue morphology was indistinguishable from that at the 
same stage of the first lactation (Fig 3.16).
Differences between non-pregnant and pregnant lactating mice were reflected 
in the pattern of stromelysin and TIMP-2 gene expression. Stromelysin was highly 
expressed on day 22 of lactation in both cases, but in concurrently pregnant mice this 
was preceded by a decrease in the expression of TIMP-2 (Fig 3.19). Therefore 
concurrent pregnancy tended to accelerate a shift in the balance between protease and 
protease inhibitor gene expression to favour epithelial degradation, presumably in 
preparation for the second lactation.
DNA laddering indicative of apoptosis was more intense in concurrently 
pregnant mice on day 16 of lactation, and increased progressively between day 16 and 
20, the penultimate day of the concurrent pregnancy (Fig 3.17). Intense laddering was 
also observed on day 1 of the second lactation (Fig 3.17). Therefore, apoptosis did not 
cease with parturition; as suggested by the tissue’s morphology, remodelling of the 
mammary glands continued during the early days of the second lactation. However, 
by day 5 of the second lactation, laddering was detected at a level similar to that 
observed in established lactation (Fig 3.17). Northern analysis detected p53 expression 
in mammary tissue of concurrently pregnant mice only on day 1 of their second 
lactation, i.e. coincident with the most intense DNA laddering. p53 is also expressed
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on day 22 of lactation in non pregnant mice (Figs 3.18 - 3.19). However, in
concurrently pregnant mice, p53 mRNA expression was preceded by a decrease in bax
table 3.2
mRNA abundance (Figs 3.18 -3.19).
3.3.4. Milk stasis
Milk stasis was induced unilaterally by teat sealing one body half, while allowing the 
dam to suckle a smaller litter from the other glands. Macroscopic tissue examination 
within 24 h of teat sealing showed milk accumulation at a whole gland level (Fig 3.20), 
and histological examination of teat sealed glands after 24 h treatment showed alveoli 
were distended with milk (Fig 3.21). After 48 h, distension had decreased, and the 
secretory epithelium showed evidence of disorganisation similar to that observed after 
litter removal at the same stage of lactation (Fig 3.21). Tissue from unsealed glands 
after 24 h was morphologically similar to that of 10 day lactating mice, however by 48 
h of teat sealing in the contralateral gland some evidence for involution was apparent 
in the suckled gland, showing that the induction of involution occurred preferentially 
but not exclusively in teat sealed glands (Fig 3.21).
The low level DNA laddering observed in day 10 lactating mouse mammary 
tissue increased progressively with 24 h and 48 h of milk stasis (Fig 3.22). The 
intensity of laddering was comparable to that observed after litter removal, suggesting 
that milk stasis was highly effective in inducing mammary apoptosis. Laddering also 
increased, albeit to a lesser degree, in contralateral glands suckled by the remaining 
pups (Fig 3.22).
Milk stasis produced ipsilateral changes in stromelysin and TIMP-2 gene 
(Table 3.2
expression (Figs 3.23). Whereas stromelysin mRNA was undetectable in day 10
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Fig. 3.20 Macroscopic appearance of mouse mammary tissue after
unilateral teat sealing. Right-side teats were sealed on day 10 of lactation 
and the animal was killed by cervical dislocation 24 h later.
A B
Duration of 
treatment
Fig. 3.21 Histology of mouse mammary tissue after unilateral teat sealing.
A, left side suckled by a reduced number of pups for 24 h and 48 h. B, 
right-side teats were sealed on day 10 of lactation for 24 h and 48 h prior to 
tissue collection. Tissue sections were stained with DAPI. Bar = 40 jum.
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Fig. 3.22 DNA laddering after unilateral teat sealing of mouse mammary 
glands in mid-lactation. Tissue was collected post mortem from sealed (S) 
and unsealed (U) mammary glands 24 h or 48 h after sealing on day 10 of 
lactation. Four animals are shown at each time point. A, ethidium bromide 
staining of resolved DNA. B, ethidium bromide staining of unresolved DNA 
in sample wells to confirm equal loading of samples. C, autoradiography of 
[32P] dCTP end-labelled DNA.
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Fig. 3.23 Comparision of gene expression induced by unilateral milk 
stasis at mid-lactation. Unilateral milk stasis was induced by teat-sealing 
half the mammary glands on day 10 of lactation. Tissue was collected post 
mortem 24 h and 48 h later. mRNA abundance was measured by 
densitometry after northern blotting and autoradiography using [32P]-labelled 
probes. Results are corrected for RNA loading and yield/g tissue, and are the 
mean ±  S.E.M. for 3 animals. Open bars, unsealed glands. Hatched bars, 
teat sealed glands.
lactating glands and in unsealed glands, its expression was increased by 48 h of milk 
stasis. This was accompanied by an ipsilateral decrease in TIMP-2 expression, 
suggesting that loss of epithelial integrity resulted, at least in part, from induction of 
extracellular proteolysis (Fig 3.23).
Preferential induction of apoptosis was associated with p53 expression in teat- 
sealed glands, and a concurrent decrease in box mRNA concentration compared with 
contralateral unsealed glands (Fig 3.23). Together, the results suggest that milk stasis 
is an effective and predominantly local i.e. intramammary regulator of mammary 
apoptosis.
3.4 Discussion
These studies showed that apoptosis is an intrinsic part of mammary involution. 
Natural weaning stimulated oligonucleosomal DNA laddering and changes in gene 
expression indicative of apoptosis, albeit with a time course different to that induced 
by litter removal. Indeed, cell death occurs before subsequent
lactations, since apoptosis occurred even in concurrently pregnant mice when 
parturition occurred 21 days after mating at the post partum oestrous. In these 
animals, there was no evidence of the delayed implantation observed in other studies 
(C.H. Knight, personal communication) and no intervening dry period between 
lactations. To accommodate a period of involution, it was clear that mammary 
apoptosis was induced earlier in concurrently pregnant mice, and to an extent 
comparable with that found after litter removal. Mammary histology and the detection 
of DNA laddering on day one of the second lactation suggested that involution and
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mammary re-development may have proceeded simultaneously in pregnant, lactating 
mice. A similar observation was made in lactating goats, which were found to be 
capable of lactogenesis and successful lactation without an intervening dry period 
(Knight and Wilde, 1988). In concurrently pregnant goats, mammary cell proliferation 
increased late in the first lactation, suggesting that milk production in the second was 
at least in part from new epithelial cells (Knight and Wilde, 1988). However, in those 
goats, as in other species including the dairy cow (Whittemore, 1980), milk yield in 
late lactation declined faster than in non pregnant controls, perhaps as a result of 
increased circulating concentrations of oestrogens which, on the basis of the present 
study, may have stimulated mammary apoptosis.
Accelerated apoptosis in concurrently pregnant mice may reflect a maternal 
decision to discontinue investment in the weanling offspring, and to invest instead in 
the next litter. Parent-offspring conflict arises because the long term interests of the 
parent are not identical with those of the offspring (Trivers, 1974). The parent’s long 
term reproductive success may be better served by premature weaning, since it would 
allow her to replenish body reserves or as in the present study, to partition nutrients 
towards the litter in utero. Triver’s cost benefit analysis showed that it is the mother 
who sets the overall strategy for parental investment. When nutrition is not limited and 
breeding does not have to be fitted into a tight reproductive window, the outcome is 
in favour of the young. When this is not the case, the outcome of the investment 
analysis is more complicated. Species with a long gestation or lactation may, even 
under adverse conditions, continue investment in young whereas, as suggested by the 
present study, rodents have little incentive to do so (Peaker, 1989).
Natural weaning, both in non-pregnant and concurrently-pregnant mice,
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occurred without any evidence of alveolar distension caused by milk stasis, indicating 
that the gradual nature of the process had allowed autocrine control to match the rate 
of milk secretion progressively to the pup’s falling demand for milk (Wilde et al., 
1995b). This distinguishes natural weaning from litter removal, when induction of 
apoptosis is likely to be a consequence not just of falling galactopoietic hormone 
concentrations (Sheffield and Kotolski, 1992; Atwood et al., 1995), but of milk 
accumulation in the glands. Teat sealing clearly identified milk stasis as an effective 
local, i.e. intra-mammary inducer of mammary apoptosis. Whether this mechanism 
is chemical in nature, or due to the physical presence of stored milk is not known. 
However, the tissue is both a source and the target of a number of growth factors, 
some of which may regulate cell death as well as cell proliferation. For example, an 
increase in transforming growth factor ill (TGFB1) and TGF133 expression during 
involution in vivo and in whole organ mammary cultures (Atwood et al., 1995), the 
ability of TGFill and TGFB3 to regulate mammary cell proliferation in non-pregnant, 
non-lactating animals (Robinson et al., 1991), and the secretion of TGF-Bs in milk 
(Letterio et al., 1994) has led to suggestions that TGF-il may regulate cell number 
during mammary involution (Atwood et al., 1995). Another possibility is that local i.e. 
intramammary depletion of insulin-like growth factor (IGF-1), a potent mammary 
mitogen (McGrath et al., 1991) and a putative cell survival factor in other tissues (Sell 
et al., 1995) may precipitate death. The IGF-1 binding protein (IGFBP) level in milk 
has been shown to increase after litter removal or galactopoietic hormone ablation to 
an extent which correlated well with the degree of involution induced by these 
treatments (Tonner et al., 1995). A further possibility is that mammary cell number 
is under autocrine control by the same FIL protein (Wilde et al., 1995a) which
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regulates milk secretion acutely and mammary cell differentiation thereafter (Wilde et 
al., 1987a, 1991).
Apoptosis induced by litter removal has been reported to coincide with 
alveolar degeneration and an increase in extracellular proteolytic activity (Strange et 
a l., 1992; Talhouk et al., 1992), raising suggestions that, as in other tissues (see for 
example, Oberhammer et al., 1991), mammary apoptosis is dependent on loss of 
basement membrane integrity. Accordingly, reconstituted basement membrane 
suppressed apoptosis in a mammary cell line, an effect counteracted by fll integrin 
antibodies, whereas over-expression of stromelysin under the whey acidic protein 
promoter induced mammary apoptosis in late pregnant transgenic mice (Boudreau et 
al., 1995). In the present study, degenerative changes in the mammary epithelium and 
reciprocal changes in protease and protease inhibitor expression were generally 
supportive of a causal relationship between basement membrane integrity and apoptosis. 
However, it was notable that appearance of DNA laddering during natural weaning 
preceded, in both non-pregnant and concurrently pregnant mice, any change in 
stromelysin or TIMP-2 mRNA. It is of course, possible that other protease activities 
are induced more rapidly than that of stromelysin e.g. gelatinase (Talhouk et al., 
1992). On the other hand, nick end labelling of fragmented DNA also detected 
apoptosis in fully lactating tissue when alveolar epithelium was apparently intact. 
Therefore, regulation of apoptosis may be more subtle, or more localised, than might 
be inferred from the widespread tissue degeneration that constitutes mammary 
involution. Localised basement membrane degradation in otherwise intact alveoli may 
stimulate apoptosis of individual cells, while neighbouring cells are protected by local 
production of protease inhibitors (Alexander and Werb, 1991; Saskela and Rifkin,
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1988).
As observed previously (Strange et al., 1992), mammary apoptosis was 
consistently associated with an increase in p53 mRNA abundance, indicating that it 
provides a useful indicator of cell death in this, as in other tissues. p53 plays a key 
role in the regulation of cell proliferation and apoptosis, in that the gene product causes 
Gl/S phase arrest (Diller et al., 1990; Michalovitz et a l., 1990), allowing DNA repair 
or, alternatively, initiation of apoptosis (Kastan et al., 1991). Mutation of the p53 
gene, or an altered level of p53 protein was frequently observed in mammary 
hyperplastic alveolar nodules (Jerry et al., 1993), the most common neoplastic 
mammary lesion in rodents (Medina, 1988). p53- mediated regulation of apoptosis is 
modified by a number of genes, one of which is bax, a member of the bcl-2 proto­
oncogene family (Wang et al., 1993; Chiou et al., 1994). Bax in turn, may be a p53 
primary response gene (Miyashita et al., 1994; Miyashita and Reed, 1995). Its role 
in apoptosis is not yet fully elucidated, but the bax gene product may either form 
homodimers and itself stimulate apoptosis, or alternatively may form heterodimers with 
the Bcl-2 protein, thereby inhibiting its suppression of apoptosis (Oltvai et al., 1993). 
The circumstances dictating whether bax stimulates or inhibits apoptosis are not yet 
well defined, and so the contrasting effects of bax on litter removal and natural 
weaning on the one hand, and pregnancy-accelerated weaning and milk stasis on the 
other, are not easily rationalised. This is particularly the case when northern analysis 
failed to detect bcl-2 gene expression at any stage of murine lactation or involution. 
TheBd-2 protein is an inhibitor of apoptosis (Vaux et al, 1992; Garcia et al., 1992), 
whereas decreased levels of the protein can render cells more susceptible to apoptotic 
death (Miyashita and Reed, 1993). The absence of bcl-2 gene expression in lactating
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or involuting rodent tissue suggests that this protein is not itself a regulator of 
mammary apoptosis. On the other hand, cyclical changes in Bcl-2 protein in human 
tissue during the oestrous cycle suggest that it may mediate the ovarian control of 
mammary cell number (Sabourin et al., 1994). Edwards et al., (1995) have also 
reported Bcl-2 and Bax protein expression in cultured mammary cells. They reported 
that both Bcl-2 andBax levels were elevated when cells were cultured without basement 
membrane, a condition which they reported to induce apoptosis. Whatever the role of 
Bsl-2 in mammary apoptosis failure to detect it under any condition may reflect more 
the insensitivity of northern analysis than the gene product’s unimportance in mammary 
apoptosis.
In conclusion, this study demonstrates that programmed cell death is part of 
the normal repertoire of the lactating and involuting mouse mammary gland. Apoptosis 
was induced not only by abrupt litter removal, but also during natural weaning, 
although the time course and extent of cell death, and its relation to other degradative 
events in mammary involution depended on the nature of the stimulus and the 
reproductive state of the animals. These studies also demonstrate a local control 
mechanism able in some instances over-ride the endocrine stimuli which signal life and 
death to a cell. In the following chapters local and endocrine regulation of apoptosis 
will be more fully explored.
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CHAPTER FOUR 
HORMONAL REGULATION OF APOPTOSIS
4.1 Introduction
In the preceding chapter we showed that apoptosis is an essential part of mammary 
involution and remodelling between lactations in rodents . When involution was 
induced naturally, by weaning, or experimentally, either by litter removal or teat 
sealing, the level of apoptosis increased within the gland.
I »
During involution the cyclical endocrine changes associated with suckling 
cease and levels of circulating prolactin fall (Ota et al., 1962; Griffith and Turner, 
1962; Jones, 1967; Richards and Benson, 1971), to result in involution of 
lobuloalveolar structure. Therefore, in rodents, prolactin has long been recognised as 
a major hormone concerned with lactogenesis and galactopoiesis. Studies have also 
demonstrated that prolactin can maintain lactation and prevent involution by regulation 
of mammary apoptosis (Sheffield and Kotolski, 1992; Atwood et al., 1995).
A role for growth hormone in the regulation of rodent mammary tissue has 
been identified, as until recently the role of growth hormone in maintaining rodent 
mammary structure and function was not clear. Increased growth hormone levels 
resulted in premature morphological development and functional differentiation (Bchini 
et al., 1991) whereas neutralisation of growth hormonal activity, by injection of 
specific antiserum, causes a 20% reduction in milk yield at peak lactation in rats (Flint 
et al., 1992). From these and other studies it appears that growth hormone is
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important in establishing lactation and in maintaining maximum milk yield in rodents 
(Madon et al., 1986; Barber et al., 1992; Flint et al., 1992).
In this study, performed in lactating rats, we investigated the relative 
importance of prolactin and growth hormone in regulation of mammary apoptosis.
4.2 Experimental protocol
Three groups of rats were treated from day 12 of lactation. In one group, involution 
was induced by litter removal. Mammary tissue was collected post mortem on day 13 
or 14 of lactation.
Hormone neutralisation was studied in the second group of rats. Prolactin or 
growth hormone were removed by injection of bromocriptine (500 jug/injection) or anti­
growth hormone serum (150 mg/injection), respectively. Other rats were treated with 
both bromocriptine and anti-growth hormone serum. Treatment was administered twice 
daily and mammary tissue was collected on day 13 or 14 of lactation.
The effect of hormone replacement after 24 h of prolactin and growth hormone 
removal was studied in a third group of rats. Lactogenic hormones were replaced on 
day 13 of lactation by injection of prolactin (500 ^g/injection) or recombinant bovine 
growth hormone (500 /xg/injection; Monsanto pic, St Louis) or both. Tissue was 
collected on day 14 of lactation. Control mammary tissue was collected from lactating 
rats on day 14 of lactation.
Litters were weighed daily and milk yield was calculated by a modification of 
the method of Sampson and Jansen (1984).
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4.3 Results
4.3.1 Lactating tissue
Milk secretion rate in day 14 lactating rats was 41 ml/d. Rat mammary tissue on day 
14 of lactation was indistinguishable histologically from mouse mammary tissue at peak 
lactation (Fig 4.1A). Tissue appeared well organised, with large, evenly sized alveoli 
which contained milk but were not distended, as expected in glands suckled frequently.
In lactating rat mammary tissue, faint DNA ladders were revealed using [32P] 
dCTP end-labelling of genomic DNA (Fig 4.2A). The intensity of laddering was 
similar to that previously detected in lactating mouse mammary tissue using the same 
method.
4.3.2 Litter removal
After 24 h of litter removal, alveoli were large and distended with secretion, compared 
with lactating rat mammary tissue (Fig 4. IB). By 48 h, alveoli were no longer 
distended, they appeared rounded and evenly spaced but there was evidence of milk 
stasis or of some secretion within alveolar spaces (Fig 4.1C). DAPI staining after litter 
removal showed crescent-shaped arrangements of nuclear chromatin (Fig 4.3), a 
phenomenon characteristic of an early phase of commitment to apoptotic death prior 
to endonuclease activation (Wyllie et al., 1980), and one which was not observed in 
mouse mammary tissue.
Litter removal produced strong DNA laddering within the first 24 h. 
Laddering was increased in intensity after the second 24 h period of litter removal (Fig
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Fig. 4.1 Histology of ra t mammary tissue. Rat mammary tissue was 
collected post mortem after various hormonal treatments, as outlined 
below. Sections were stained with haematoxylin and eosin. AGS, anti 
growth hormone serum, BR, bromocriptine, GH, growth hormone, 
PRL, prolactin. Bar =  40 ^m. Treatments commenced on day 12 or 
13 of lactation and all tissue was collected on day 14 of lactation.
A Control
B, One day, litter removal
c, Two days, litter removal
D, One day AGS
E, Two days BR
F, One day AGS +  BR
G, Two days AGS +  BR
H, Two days AGS +  BR including one day GH
I, Two days AGS +  BR including one day PRL
J, Two days AGS +  BR including one day GH +  PRL

A B C D E F G H
Fig. 4.2 DNA laddering of rat mammary tissue. Rat mammary tissue was 
collected post mortem after various hormonal treatments as outlined below. 
DNA was [32P] dCTP end labelled prior to electrophoresis. AGS, anti growth 
hormone serum. BR, bromocriptine. GH, growth hormone, PRL, 
prolactin.
A, Control tisssue
B, One day of litter removal
C, Two days of litter removal
D, One day AGS + BR treatment
E, Two days AGS 4- BR treatment
F, One day AGS + BR followed by one day GH
G, One day AGS + BR followed by one day PRL
H, One day AGS + BR followed by one day GH + PR
Fig. 4.3 Evidence for early changes characteristic of apoptosis in rat 
mammary tissue. Tissue was collected from the dam, post mortem, after 24 
h of litter removal on day 12 of lactation. Sections were stained with DAPI. 
Arrows, cresented nuclei. Bar = 5 pm.
4.2).
4.3.3. Hormone neutralisation
Milk secretion rate after 48 h prolactin and growth hormone deficiency was 8 ml/d, 
which represented an 80% reduction compared with untreated controls. Simultaneous 
removal of prolactin and growth hormone resulted in morphological changes similar 
to involution, and after 48 h of dual hormone depletion epithelial cell loss was apparent 
and adipose tissue infiltration was clearly visible (Fig 4.1). During this period DNA 
content decreased by 37% (D.J. Flint, personal communication), a decrease which was 
attributable to apoptosis. DNA laddering increased within 24 h in hormone depleted 
rats, and after 48 h ladder intensity was greater than that observed with litter removal 
(Fig 4.2).
Milk yield was also reduced after removal of prolactin or growth hormone 
alone. Treatment for 48 h with anti-growth hormone serum reduced milk yield by 15 % 
while treatment with bromocriptine for 48 h reduced milk yield by 50%. Therefore, 
single hormone removal reduces milk yield but not to the same extent as after depletion 
of both growth hormone and prolactin. DNA laddering and histology after 24 h growth 
hormone removal remained indistinguishable from control lactating tissue (Fig 4.1,
4.4). DNA ladders were slightly more prominent after 24 h prolactin removal than in 
control lactating tissue (Fig 4.4) and alveoli were engorged with a secretion which had 
a higher lipid content than milk from control animals (D. Flint, personal 
communication; Fig 4.1).
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Figure 4.4 Nick end-labelling of rat mammary DNA. DNA was [32P] 
dCTP end-labelled after various hormonal treatments as outlined below. 
AGS, anti growth hormone serum, br, bromocriptine, GH, growth 
hormone. PRL, prolactin.
Control - day 14 of lactation 
Litter removal - 48 h 
AGS - 24 h 
br - 24 h 
AGS +br - 48 h
AGS+br+GH - AGS+br for 48 h including GH for 24 h 
AGS+br+PRL - AGS+br for 24 h including PRL for 24 h.
4.3.4 Hormone replacement
Replacement of growth hormone for 24 h after a similar period of double 
hormone depletion partially restored milk secretion rate to 23 ml/d. This represented 
an increase compared with hormone-depleted animals but a decrease compared with 
controls at the same stage of lactation. Histologically, tissue organisation and alveolar 
integrity was more structured than that observed in tissue after dual hormone depletion 
but tissue did not appear to be as organised as control lactating tissue (Fig 4.1). On 
the other hand, growth hormone replacement did not decrease the extent of DNA 
laddering (Fig 4.2, 4.4).
With prolactin replacement, milk secretion rate recovered to 29 ml/d. 
Alveolar structures were more apparent after prolactin replacement suggesting this 
treatment produced a partial recovery of tissue organisation (Fig 4.1). Prolactin 
replacement reduced the extent of DNA laddering to a level similar to that detected in 
control tissue (Fig 4.2, 4.4).
Replacement of both prolactin and growth hormone did not restore milk 
secretion to control rates. After 24 h of dual hormone replacement in rats the milk 
secretion rate was 30 ml/d, similar to that observed with prolactin alone. However, 
dual hormone replacement restored tissue histology to that of day 14 lactating tissue 
(Fig 4.1), and DNA laddering was reduced to control levels in the tissue (Fig 4.2,
4.4).
4.4 Discussion
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Litter removal in rats increased DNA laddering in mammary tissue, as it did in mice. 
DNA ladders of increasing intensity were detected within 24 h of litter removal and 
remained high in the following 24 h period. However, some mechanistic differences 
were detected in the process of apoptosis in mice and rats. In mice, epithelial cells 
were shed into the lumen during apoptosis; this was not observed during rat mammary 
apoptosis. Another difference between mice and rats was observed by DAPI staining, 
which revealed crescent-shaped nuclei in rat tissue after 24 h litter removal. 
Crescented nuclei, which have been reported to form prior to endonuclease activation 
(Walker et al., 1988) were detected in rat tissue at a time when gland DNA content had 
not yet decreased (D.J. Flint, personal communication), suggesting that a number of 
cells were poised to enter apoptosis. Crescent-shaped nuclei are also a feature of 
mitotic cells or may also be detected, artifactually, in tissue sections due to the plane 
of sectioning. However, detection of these structures in involuting rat but not mouse 
mammary tissue argues against artefactual apoptotic crescents and suggests that subtle 
differences may even exist in the apoptotic process of closely related species.
Milk secretion can be interrupted either by removal of the suckled young, 
whereupon milk accumulation occurs and milk synthesis ceases, or by hormonal 
deprivation, when milk synthesis is markedly decreased but milk removal continues due 
to the presence of the young. These two models provide a useful comparison of 
involution induced by hormonal withdrawal with that induced by milk stasis within the 
gland. Intense apoptosis detected in both situations highlights the multifactorial control 
of apoptosis. Lactation is only maintained while both milk removal and galactopoietic 
hormone release are maintained.
The enhanced DNA laddering after prolactin neutralisation was consistent with
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other studies where prolactin has been shown to be essential for maintaining lactation 
and inhibiting apoptotic cell death in mammary tissue (Sheffield and Kotolski, 1992; 
Atwood et al., 1995). Prolactin neutralisation was also accompanied by a decreased 
milk yield, probably due to a reduced cell number in the gland. It is not known if this 
fall in cell number is a direct effect of the inhibition of the apoptotic machinery by 
prolactin, or if it is an indirect consequence of milk stasis. Prolactin withdrawal 
resulted in the production of a highly viscous lipid-rich milk which may inhibit milk 
removal by the pups. When pups do not or cannot obtain milk from their mother milk 
accumulates within the gland and autocrine feedback decreases milk secretion from 
these glands (Wilde et al., 1995a). In this respect, prolactin withdrawal may be 
likened to studies where milk composition has been altered by decreasing the a- 
lactalbumin gene. Mice deficient in a lactalbumin produced a viscous milk with a high 
lipid content and resulted in death of the pups due to an inability to remove this milk 
from the mother (Stacy et al., 1995). The production of a lipid-rich milk suggests that 
individual milk constituents can be regulated by different hormonal controls. During 
development the detection of B casein after day 8 of gestation (Sympson et al, 1994) 
and of whey acidic protein only beyond day 14 of gestation (Pittius et al., 1988a,b; 
Sympson et al., 1994) suggests different milk constituents can be separately regulated. 
Recent work has also shown B casein to be regulated by laminin (Streuli et al., 1995a) 
whereas whey acidic protein is regulated by collagen (Lin et al., 1995). Therefore 
although some factors, including autocrine factors, may regulate milk secretion 
coordinately (Wilde et al., 1995b), differential regulation of individual constituents is 
also likely.
The effect of growth hormone withdrawal was a slight reduction in milk yield;
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conversely, one effect of growth hormone replacement was increased milk yield. 
Removal of either growth hormone or bromocriptine reduced milk yield to differing 
extents and subsequent re-instatement of growth hormone or prolactin resulted in a 
partial restoration of milk yield. The increased effectiveness of prolactin in inducing 
changes in milk yield suggests a different mechanism of action for prolactin and growth 
hormone. Prolactin activity primarily caused changes in the rate of apoptosis whereas 
growth hormone did not affect DNA laddering. The effect of growth hormone was 
more obvious after dual hormone withdrawal when growth hormone was replaced. In 
this instance, gland morphology recovered towards that observed in lactation, and milk 
yield increased to a level comparable with that achieved with prolactin in similar 
circumstances. This suggests that growth hormone does indeed influence milk yield, 
but may be acting at the level of cellular differentiation rather than at the level of cell 
death.
Growth hormone altered the extent of apoptosis only when acting in 
conjunction with prolactin. Apoptosis induced by prolactin withdrawal increased when 
growth hormone was also removed, as was the effect on milk yield. Likewise, the 
decrease in mammary apoptosis after prolactin replacement in bromocriptine and anti 
growth hormone treated rats was much greater if growth hormone was also replaced. 
This demonstrates a role for growth hormone throughout lactation, and suggests that 
growth hormone levels can alter the gland’s response to prolactin. Indeed growth 
hormone has been demonstrated as important for maintaining milk production in the 
rat when circulating prolactin concentrations are low (Madon et al., 1986; Barber et 
al., 1992; Flint e ta l., 1992).
This study provided the first attempt, to our knowledge, to reverse the
70
progression of mammary apoptosis. Reversibility of the rate of apoptosis suggests 
asynchrony in the time taken after the application of an apoptotic stimuli for different 
epithelial cells to reach a "point of no return" from apoptotic death. Prolactin acted 
as a cell survival factor when replaced alone, and when added together with growth 
hormone. The survival mechanism due to prolactin administration is not understood, 
but recent experiments suggest that prolactin, unlike progesterone or glucocorticoid, 
does not influence mammary cell survival by a local mechanism (Feng et al., 1995). 
It therefore seeems most likely that prolactin acts systemically or by an indirect mode 
of action. Cellular response to prolactin involves a large number of cells, as can be 
illustrated by the increase in DNA laddering within 24 h of prolactin withdrawal and 
also by the reversal in apoptotic rate after 24 h of prolactin replacement.
In this chapter the effects of prolactin and growth hormone have been 
investigated during rodent lactation. The role of these two hormones is known to differ 
during the lactation cycle of rodents and ruminants. It is therefore likely that growth 
hormone and prolactin play different roles in altering cell susceptibility to apoptosis in
i
rodents and ruminants. With this in mind a study of apoptosis during ruminant 
lactation and involution will be described in Chapter 5.
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CHAPTER FIVE 
APOPTOSIS IN RUMINANT LACTATION
5.1 Introduction
In the preceding chapters, cell loss during involution in mice and rats was shown to 
occur by apoptosis. This process was induced when milk removal ceased, for example 
when a litter was removed from the mother during lactation. Indeed, it appeared to be 
a prerequisite for mammary remodelling in preparation for the next lactation. 
Apoptosis occurred when the young were weaned onto solid food, progressively taking 
less milk from the dam. Apoptotic cell removal occurred even when the interval 
between each lactation cycle was reduced to a minimum by mating at post partum 
oestrus.
Some of the factors which regulate apoptosis in mammary tissue have been 
identified. In this project manipulation of hormonal status in the rat has been shown 
to result in reversibly-inducible cell loss by apoptosis, and the existence of local control 
mechanisms sensitive to milk stasis has been demonstrated in the mouse. It is therefore 
probable that both local and systemic factors are involved in the induction of apoptosis 
after litter removal or natural weaning in mice.
In contrast to the extensive literature on regulation of mammary cell number 
in rodents, the role of apoptosis in ruminant lactation is unclear. Indeed, cell loss 
between lactations is thought to be less important in ruminants than in rodents (Hurley 
et al., 1989). However, during declining lactation in goats (weeks 8 - 23) a 50 % 
reduction in cell number occurs (Knight and Peaker, 1984). This suggests that cell
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removal may be important during declining lactation.
This study was undertaken to determine if goat mammary cell loss during 
declining lactation is due to apoptotic death and if so, whether it is subject to regulation 
by local intra-mammary mechanisms sensitive to milk removal.
5.2 Experimental protocol
5.2.1 Unilateral milk stasis
Twelve goats were milked twice daily throughout lactation. During declining lactation 
(week 25 - 41 of lactation) the right gland was dried off while the left gland continued 
to be milked twice daily. After 2 days, 1, 2 or 3 weeks of unilateral milking, tissue 
samples were taken from each mammary gland post mortem.
5.2.2.Unilateral manipulation of milking frequency
Four goats were allowed to suckle their young to establish lactation. On day 4-5 of 
lactation the goats were milked, individual-gland milk yield from each gland was 
measured and a biopsy was taken from each mammary gland (pre-treatment samples). 
The right gland was then switched to thrice daily milking while the left gland was 
milked once daily. Milk yield of each gland was recorded. After 4 weeks of this 
treatment a biopsy was taken from each gland (post-treatment samples).
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5.3 Results
5.3.1 Unilateral milk stasis
Tissue from glands milked twice daily throughout declining lactation showed tissue 
morphology characteristic of secretory tissue with no evidence of involution at any 
stage (Fig 5.1, 5.2). Ethidium bromide staining did not detect DNA laddering in 
milked glands. However, [32P] dCTP nick end-labelling of DNA revealed DNA 
laddering in milked glands which increased in intensity with duration of milk stasis in 
the contralateral gland (Fig 5.3).
Histological study showed tissue disorganisation in unmilked glands, which 
increased with duration of milk stasis (Fig 5.1, 5.2). After three weeks of unilateral 
milk stasis the morphology of the unmilked gland had degenerated to such an extent 
that alveolar organisation was no longer apparent (Fig 5.1, 5.2). DNA laddering was 
detected by [32P] end-labelling DNA from unmilked glands after two days of treatment 
(Fig 5.3). Laddering in the unmilked glands increased in intensity with duration of 
milk stasis and was consistently of greater intensity than that observed in milked glands 
(Fig 5.3).
5.3.2 Effects of unilateral manipulation of milking frequency
In a second experiment goats in early lactation were unilaterally milked once and thrice 
daily. Average milk yield of thrice daily milked glands was consistently higher than 
that of contralateral once daily-milked glands (Table 5.1). The change in yield of the 
two glands was compared by calculation of the relative milk yield quotient (RMYQ). 
For each goat the RMYQ was greater than unity after 4 weeks of unilateral milking, 
indicating that milk yield had increased in the thrice daily milked gland compared to
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Milked Unmilked
3 weeks
Fig. 5.1 Histology of goat mammary gland after unilateral cessation of 
milking . Tissue was collected post mortem from glands milked or unmilked 
for 2 days or 3 weeks during declining lactation. Sections were stained with 
Casson’s Trichrome. Bar = 200 pm.
12
Fig. 5.2 Histology of goat mammary gland after unilateral cessation of 
milking. Tissue was collected post mortem from glands milked or unmilked 
for 2 days, or 1,2 or 3 weeks during declining lactation. Sections were 
stained with haematoxylin / eosin. Bar = 40 pm.
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Fig. 5.3 DNA laddering induced by unilateral milking in declining 
lactation. A, ethidium bromide staining of electrophoresed genomic DNA. 
B, ethidium bromide staining of unresolved DNA to confirm equal loading 
of DNA. C, autoradiography of [32P] d CTP end-labelled DNA. M, milked 
glands. U, unmilked glands.
Treatment
Milk yield 
pre (kg/d)
Milk yield 
post (kg/d) RMYQ
3x 0.87 2.24 1.19
lx 0.80 1.73
3x 1.23 2.53 1.52
lx 1.22 1.65
3x 1.01 2.47 1.60
lx 0.86 1.31
3x 1.98 3.05 1.76
lx 2.15 1.88
Table 5.1 Milk yield after once or thrice daily milking. Milk yield was 
recorded for each gland after each milking. Relative milk yield quotient 
(RMYQ) was calculated as (a /cl) / (ti/ c2), where cl is the pretreatment milk 
yield of the control gland, t2 is the pretreatment milk yield of the test gland, 
c2 is the milk yield of the control gland after once daily milking had 
commenced and t2 is the milk yield of the test gland after thrice daily milking 
had commenced. A RMYQ value > 1 shows the test gland increased since the 
previous period relative to the control gland.
the once daily milked gland, regardless of initial yield of each gland and over and 
above any effects due to stage of lactation (Table 5.1). There was a marked change 
in the level of DNA laddering during the experimental period. Extensive DNA 
laddering was detected in all pre-treatment samples, and was uniformly less intense in 
all post-treatment samples. No differences were seen in DNA laddering of post­
treatment samples, irrespective of milking frequency (Fig 5.4). Tissue from pre­
treatment samples was histologically indistinguishable from once or thrice-daily milked 
tissue at peak lactation (Fig 5.5).
5.3.3 Goat mammary gene expression
Probes used in the study of mouse mammary apoptosis were tested for cross 
hybridisation with lactating and involuting goat RNA. Of these only T1MP-2 and bax 
cross hybridised with goat RNA. Therefore, in the absence of more comprehensive 
information, results are not presented.
5.4 Discussion
Apoptosis was detected throughout ruminant lactation, however the extent of apoptosis 
varied according to the stage of lactation. Intense DNA laddering was detected in the 
first days of lactation, a time when cell division occurs in the mammary gland 
(Anderson et al., 1981; Knight and Peaker, 1984). Therefore, mammary development 
in early lactation may well involve mitosis and simultaneous apoptosis. The apoptosis 
detected during mammary development in early lactation may represent death of 
epithelial cells, however the removal of other cell types is a distinct possibility, since
75
Post-treatment samples 
lx 3x lx 3x lx 3x lx 3x
Fig. 5.4 DNA laddering before and after unilateral alteration of milking 
frequency. Goat mammary tissue was collected by biopsy before (Pre­
treatment) and after 4 weeks of milking one gland once daily (lx) and the 
other gland thrice daily (3x).
4 animals were used (1,2, 3 and 4). L, left hand side. R, right hand side.
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Fig. 5.5 Histology of once and thrice daily milked glands. Goat mammary 
tissue was collected by biopsy before (pre-treatment) and after 4 weeks of 
milking one gland once daily (lx) and the other gland thrice daily (3x). 
Sections were stained with haematoxylin / eosin. Bar = 16 jum.
in the rodent mammary gland apoptosis of epithelial and myoepithelial cells has been 
reported (Walker et a l., 1989). During many developmental processes in other tissues, 
for example during the development of C. elegans, high mitotic indices coincided with 
high levels of apoptosis (Yuan and Horvitz, 1992).
Demonstration of DNA laddering, at peak lactation, albeit at a low level, 
suggests that cell turnover is a normal physiological process in lactating ruminant 
mammary tissue. Laddering was also detected in declining lactation, at a time when 
mammary cell number was decreasing progressively (Knight and Peaker, 1982a). 
Therefore, the fall in milk yield which characterises much of lactation in ruminants 
may well be due to cell removal through programmed cell death.
In lactating goats, the effects of milking frequency on milk yield, mammary 
cell secretory activity and mammary cell number have been well documented 
(Henderson et al., 1983; 1985; Knight and Wilde, 1987; Wilde et al., 1989; 1991), 
whereas the importance of cell death and the role of apoptosis is unknown. There was 
no difference in the extent of DNA laddering induced under once or thrice daily 
milking in early lactation: instead changes in DNA laddering in the two glands in early 
lactation reflect differences due to stage of lactation rather than effect of milking 
regime. In both cases, laddering decreased dramatically after 4 weeks of treatment 
compared to a few days of lactation. This suggests that short term alterations in 
milking frequency do not alter cell number or apoptosis in the tissue. Nevertheless, 
the milk-yield of thrice daily milked glands was consistently higher than once daily- 
milked glands. This suggests that short term alterations of milking frequency do not 
lead to changes in cell number, but that the altered milk yield is achieved through 
changes in cell differentiation. Indeed, markers of cell differentiation were elevated
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in thrice daily milked glands as compared to once daily milked glands (J. Brown, 
personal communication) and milk protein mRNA abundance was higher in thrice daily 
milked glands than in once daily milked glands (J. Bryson, personal communication). 
Therefore this study supports previous data which show short term milking responses 
are due to cell differentiation responses. Short term once daily milking resulted in 
decreased milk yield due to reduced differentiation of secretory cells (Wilde et al., 
1989; Wilde and Knight, 1990). Conversely the increase in milk yield due to short 
term thrice daily milking has been found to be due to increased secretory cell 
differentiation (Akers and Heald, 1978; Wilde et al., 1987b).
To produce changes in the level of mammary apoptosis which might account 
for the effect of milking frequency on cell number observed in earlier studies the 
milking stimuli must be of long duration or more intense nature. When frequent 
milking was sustained for several months gland size increased, suggesting either growth 
or reduced regression of the thrice daily milked gland (Wilde et al., 1987b). An 
increase in DNA synthesis due to long term thrice daily milking (26% higher after 37 
weeks of treatment) suggested a growth response as opposed to merely a reduction in 
the rate of involution (Wilde et al., 1987b). However, the fact that proliferation was 
increased does not rule out the possibility of reduced cell death.
The stimulus of milk stasis was so intense that an increase in apoptosis was 
initiated within one week. DNA laddering increased with duration of milk stasis, 
indicating that apoptosis was increased as involution progressed in goat mammary 
tissue. Therefore, as in rodents, apoptosis plays a central role in cell removal after 
milking ceases. The mechanism of local control of apoptosis, demonstrated during 
unilateral cessation of milking in goats, is not yet understood. However, it is likey that
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a similar mechanism operates in rodents since local control of apoptosis has been 
demonstrated after unilateral teat sealing in mice (Chapter 3). Local control in 
mammary tissue may be due to the physical presence of milk in the gland or may be 
chemical in nature. A constituent responsible for autocrine control has been purified 
and termed FIL (feedback inhibitor of lactation; Wilde et al., 1995a). The role this 
factor plays influencing apoptotic rates in the mammary gland has yet to be 
investigated. In goats, evidence for increased apoptosis was also apparent in milked 
glands with increased duration of cessation of milking in the contralateral gland, albeit 
to a lesser degree than in non-milked glands. The same was also true during unilateral 
teat sealing in mice, where apoptosis was always more prevalent in sealed glands but 
apoptosis also increased with duration of teat sealing in sealed and unsealed glands. 
These obsevations in ruminants and rodents suggest a role for systemic influence during 
local control of apoptosis.
The detection of DNA laddering in early lactation, at peak lactation, in 
declining lactation and during gland involution suggests that apoptosis is part of the 
normal repertoire of goat mammary tissue. It had been suggested that involution and 
cessation of milk production in the dairy cow does not involve massive cell death 
(Hurley et al., 1989). However, the widespread incidence of apoptosis in ruminant as 
in rodent mammary gland during involution highlights similarities in the importance of 
apoptosis in the two species despite selection of ruminants for milk production.
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CHAPTER 6
MECHANISM OF MAMMARY APOPTOSIS
6.1 Introduction
Apoptosis was observed consistently and on a significant scale at the end of lactation 
in mice, rats and goats. These studies demonstrated that apoptosis was regulated by 
both the endocrine system and by locally acting factors operating within the gland. The 
two mechanisms, either alone or in combination induced apoptosis after teat sealing, 
litter removal or during natural weaning in rodents. Local and endocrine mechanisms 
also combined to regulate apoptosis in ruminants, as demonstrated by detection of cell 
death in milked and unmilked glands after unilateral cessation of milking.
A mammary epithelial cell culture system was required to investigate the 
regulatory mechanisms indicated by the in vivo experiments. The use of recently 
developed cell culture techniques has enabled culture of epithelial cells upon a layer of 
reconstituted basement membrane extracted from Engelbreth-Holm-Swarm mouse 
tumour (EHS matrix; Barcellos-Hoff et al., 1989, Aggeler et al., 1991). The EHS 
matrix provides a scaffolding of extracellular constituents which mimics the basement 
membrane that surrounds mammary epithelial cells in vivo. This EHS matrix contains 
laminin, collagen, fibronectin and a variety of uncharacterised extracellular components 
which can alter the behaviour of adjacent cells. Use of the EHS matrix during 
mammary epithelial cell culture enabled study of differentiated rather than proliferating 
cells and the mechanisms of vectorial milk secretion (Barcellos-Hoff et al., 1989; 
Aggeler et al., 1991; Talhouk et al., 1992; Streuli et al., 1993; Blatchford et al.,
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1995). The interactions between mammary epithelial cells and the extracellular matrix 
were examined in this system to determine if it offered a means of studying the 
mechanism and regulation of mammary apoptosis.
6.2 Experimental protocol
In the previous chapters apoptosis has been studied by inducing cell death in well 
differentiated cells in vivo. To sucessfully study apoptosis in a cell culture system the 
mammary epithelial cells were plated on top of a layer of EHS matrix as this is the best 
way to obtain well differentiated cells in culture. The epithelial cells on EHS 
differentiated to form alveolar like structures with a central lumen, a situation which 
resembles mammary cell assembly in vivo. Therefore this cell culture system 
combined the study of relationships between mammary structure and function with 
advantages of cell accessability, to enable a more complete dissection of the regulation 
of apoptosis than is possible from in vivo studies.
The incidence of DNA laddering was studied throughout the period of cell 
culture, but a peak of endonuclease activity at the third day of culture focussed 
attention on the role of apoptosis during mammosphere formation. The mechanism of 
apoptosis during the initial days of culture was investigated by laminin staining of 
mammosphere structures and by determining levels of insulin growth factor binding 
proteins (IGFBP’s) in conditioned media.
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6.3 Results
In the first few days of culture cells plated as clumps of cells attatched to the matrix 
and then gradually became enshrouded in matrix which was pulled from the tissue 
culture plastic (Fig 6.1). Initially these structures contained a core of epithelial cells, 
however after several days in culture the clumps of cells became hollow consisting of 
a complete sphere of cells enclosing one or more large central spaces or lumina (Fig 
6.2). These structures are termed mammospheres. Vectorial 15 casein secretion was 
observed after day 3 of culture (Fig 6.3). Whey acidic protein, which is secreted by 
differentiated mammary epithelial cells, was detected after day 3 of culture, and was 
also secreted vectorially in the forming luminal space of the mammospheres (Fig 6.4). 
Not all milk proteins exhibited vectorial secretion after mammosphere formation. For 
example, transferrin was released from basal and apical cell surfaces before and after 
lumen formation (Fig 6.5).
DNA laddering was detected throughout the course of culture (Fig 6.6) and 
was consistently higher throughout the culture period than during lactation in mice (data 
not shown). On the third day of culture laddering was particularly intense (Fig 6.6). 
This transient increase in DNA laddering coincided with lumen formation. DNA 
laddering also coincided with detection of apoptotic bodies which were observed at day 
3 and 4 of culture (Fig 6.7). Apoptotic bodies were localised to central areas of the 
mammospheres (Fig 6.7), whereas nuclear chromatin appeared intact in peripherally 
located nuclei.
Prior to lumen formation, immunocytochemical staining revealed peripheral 
cells (Fig 6.8) in contact with laminin (the major component of the extracellular 
matrix), while cells in the centre of the clump were not associated with laminin (Fig
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Figure 6.1 Appearance of mouse mammary cell clumps plated on 
extracellular matrix. Cell clumps were plated on extracellular matrix for 10 
days. Cells were photographed on day 1,3,5 and 8, just prior to a daily media 
change. Days 1 and 3 bar = 200 ptm. Days 5 and 8 bar = 30 /zm.
Figure 6.2 Formation of lumina in mouse mammary cell clumps. Cells 
were fixed in 4% (w/v) paraformaldehyde on days 2 and 5, harvested by cell 
scraping and embedded in OCT for frozen sectioning. 5/nm sections were 
visualised by phase microscopy to visualise lumina formation. Bar = 50 ^m.
DAPI ft casein
Figure 6.3 Secretion of milk components by the mouse mammospheres.
5jum frozen sections of cell clumps at days 2 and 5 of culture were stained 
with anti-mouse ft casein antibody, counterstained with DAPI and visualised 
by fluorescent secondary reagents. Sections were visualised by fluorescent 
microscopy. Bar = 50 /x,m.
DAPI whey acidic protein
Figure 6.4 Secretion of milk components by the mouse mammospheres.
5/xm frozen sections of cell clumps at days 2 and 5 of culture were stained 
with anti-mouse whey acidic protein antibody, counterstained with DAPI and 
visualised by fluorescent secondary reagents. Sections were visualised by 
fluorescent microscopy. Bar = 50 /xm.
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Figure 6.5 Secretion of milk components by the mouse mammospheres.
5/xm frozen sections of cell clumps at days 2 and 5 of culture were stained 
with anti-mouse transferrin antibody, counterstained with DAPI and visualised 
by fluorescent secondary reagents. Sections were visualised by fluorescent 
microscopy. Bar =  50 jum.
Days of
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These epithelial cell samples are unlikely to contain any extracellular matrix, as the cell 
harvesting method (as described in 2.3.2) involved use of dispase, an enzyme that was used to 
strip the epithelial cells away from the extracellular matrix, farther, cells were also washed in 
culture media between harvesting and DNA extraction procedures (as described in 2.3.2) and 
therefore any laddering due to extracellular matrix ought to be eliminated.
Figure 6.6 DNA laddering in mouse mammary epithelial cells on EHS 
matrix. Cells were harvested daily with dispase, genomic DNA was isolated 
using the Puregene DNA kit, and DNA was nick-end labelled with [32P] dCTP 
prior to electrophoresis and autoradiography. A, ethidium bromide staining 
of unresolved DNA in sample wells. B, DNA fragmentation visualised by
autoradiography. xhiS experiment was repeated three times.
Figure 6.7 Apoptotic bodies within the mouse mammary cell clumps at
day 3 or 4 of culture. 5/xm sections of mouse mammospheres stained with 
DAPI and visualised by fluorescent microscopy. Bar = 5 jinn.
Day 2
Figure 6.8 Laminin staining of mouse cell clumps. 5^m sections of cell 
clumps at days 2 and 5 of culture were stained for presence of laminin and 
staining was visualised by diaminobenzidine. Bar = 50 /urn.
6.8). After lumina had formed, laminin was detected as a thicker layer on the 
periphery of the mammosphere and was absent from the mammosphere interior (Fig
6.8). Whether this thickening is due to laminin secretion by the outer cells or to 
appropriation from the matrix is unclear. Expression of stromelysin or TIMP-2 mRNA 
was not detected throughout the first five days of culture.
IGFBP’s were detected in conditioned media, by ligand blotting, in 
progressively diminishing amounts throughout the first 3 days of culture (Fig 6.9). 
These IGFBP’s were present on day 1, were detected in greatly reduced concentration 
in day 2 culture medium and were almost absent on day 3 apart from one IGFBP. This 
was probably due to residual IGFBP’s contained in serum used during the first day of 
culture. The IGFBP which remained detectable in conditioned media on the third day 
of culture was of molecular weight 30kDa (D.Flint, personal communication), 
suggesting that the protein was IGFBP 4 or IGFBP 5. Northern analysis, using a rat 
cDNA probe, was unable to confirm elevated levels of IGFBP 4 or IGFBP 5 mRNA 
on day 3 of culture. This may have been due to lack of cross hybridisation of the rat 
cDNA with mouse RNA.
Milk secretion by these mammosphere structures has been shown to occur 
vectorially and basolaterally by two pathways, one a calcium independent constitutive 
pathway, the other a regulated pathway stimulated by elevation of intracellular calcium 
(Blatchford et a l., 1993). Of all the protein secreted by the mammospheres 41.3 + 7% 
has been shown to be secreted vectorially (Blatchford et al., 1995), this value was 
within the range reported by other laboratories (Barcellos-Hoff et al., 1989; Seely and 
Aggeler, 1991). Vectorial milk secretion was not just a feature of day 5 
mammospheres as even at day 8 and 9 of culture the mammospheres were still
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Figure 6.9 IGFBP levels in conditioned media from mouse mammary cells 
cultured on EHS. IGFBP’s were detected by ligand blotting of conditioned 
media collected on days 1-5 of culture. The ligand blot was performed by 
Miss E. Tonner.
secreting milk proteins in a vectorial manner. However, at this stage of culture there 
was evidence of cell proliferation in the area surrounding the mammosphere which had 
been depleted of extracellular matrix (Fig 6.1). A slight increase in DNA laddering 
was observed at this stage of culture (Fig 6.6).
6.4 Discussion
The extracellular matrix is recognised to be a vital component of the cellular 
environment (Adams and Watt, 1990; Streuli et al., 1991). Various extracellular matrix 
components are secreted by cells to form a framework on which cells can be anchored 
(Streulli et al., 1991; Howlett and Bissell, 1993; Chang at al., 1995, Tremble et al., 
1995). Thus the extracellular matrix provides spatial orientation and stability for cell 
organisation and tissue development (Kleinman et al., 1986; Li et al., 1987; Barcellos- 
Hoff et al., 1989; Chen et al., 1989; Aggeler et al., 1991). The extracellular matrix 
is not merely a scaffolding, it also takes part in the regulation of cell growth and 
differentiation (Adams and Watt, 1990; Streuli and Bissell, 1990; Bissell and Barcellos- 
Hoff, 1991).
The structure and function of normal mammary epithelia is dependent upon 
signals from the mammary extracellular matrix (Li et al., 1987; Schmidhauser at al., 
1990; Aggeler at al., 1991; Seely and Aggeler, 1991; Streuli et al., 1991). Mammary 
differentiation is controlled through co-operation between extracellular components and 
lactogenic hormones (Topper and Freeman, 1980, Schmidhauser et al., 1990; Talhouk 
et al., 1992, Vollmer at al., 1993; Politis et al., 1995). The laminin-rich basement 
membrane, along with lactogenic hormones, has been shown to activate transcription
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of milk proteins including 6 casein (Li et al., 1987; Streuli et al., 1991, 1995a) and 
whey acidic protein (Chen and Bissell, 1989; Lin et al., 1995). Experiments in this 
chapter show that epithelial cell differentiation commenced during formation of the 
lumina, at days 3-5 of culture, a time at which vectorial milk secretion commenced.
The formation of lumina had previously been assumed to be due to cell 
movement of central cells towards the periphery of the cell clump. However an 
increase in DNA laddering at the time of lumen formation suggested the involvement 
of apoptosis. The presence of apoptotic bodies in the mammospheres confirmed that 
increased apoptosis was taking place during lumen formation. These apoptotic bodies 
were located in the centre of the mammospheres suggesting that luminal spaces were 
created by cell death rather than cell movement. In short, cell localisation appeared 
to determine cell fate.
The mechanisms of selective cell survival remain unclear. One candidate cell 
survival factor is the EHS component, laminin. Laminin is recognised by a 1/151 and 
<*6/111 integrin receptors (Hall et al 1990), which have been demonstrated as inducers 
of differentiation and B casein production (Streuli et al., 1991). More recently laminin, 
through a specific site in its globular domain has been shown to interact functionally 
with mammary epithelial cells to activate B casein gene transcription (Streuli et al., 
1995a) and apoptosis has been induced on addition of B1 integrin antibody to culture 
medium of a mammary cell line (Boudreau et al., 1995). This evidence suggests that 
extracellular laminin acts through integrin receptors to influence intracellular molecules 
and prevent apoptosis in mammary cells.
In the mammosphere system, cell contact with laminin seemed to be a pre­
requisite for survival. The antibody used for detection of laminin production by mouse
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mammary epithelial cells also inevitably detected laminin contained in extracellular 
matrix extracted from the mouse EHS tumour. This staining confirmed peripheral cell 
contact with matrix laminin during the early stages of culture and a relative absence of 
laminin in the core of the mammosphere. Therefore, laminin seemed to be in contact 
only with peripheral cells, and it was these cells which survived to form 
mammospheres. Cells within the clump did not sequester laminin and it was these cells 
which died, resulting in a hollow sphere of cells. Later in culture, after day 5, the 
laminin layer around the periphery of the mammosphere appeared even more densely 
stained than the surrounding matrix, suggesting that once the mammary epithelial cells 
have differentiated they may secrete laminin basolaterally (Streuli and Bissell, 1990; 
Howlett and Bissell, 1993).
Loss of contact with the basement membrane can induce changes in 
differentiation in some cell systems for example keratinocyte terminal differentiation 
is triggered by loss of extracellular matrix (Adams and Watt, 1990) and in other 
systems loss of basement membrane contact can induce death, for example survival of 
differentiated hepatocytes is dependent upon extracellular matrix - cell contact (Schuetz 
and Schuetz, 1993), demonstrating a causal link between membrane contact and 
survival. Therefore the proposed role for contact with laminin as a cell survival factor 
is not unique to mammary tissue.
Previous investigators of apoptosis during gland involution have correlated 
increased protease activity due to alterations in the protease : protease inhibitor ratio, 
with advancing apoptosis (Strange et al., 1992, Talhouk et al., 1991). During 
involution proteases destroy the extracellular matrix and this protease activity produces 
folds and convolutions in the extracellular matrix (Walker et al., 1989). This activity
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breaks the contact between epithelial cells and the basement membrane, and this is 
thought to induce apoptosis in the cells which lose basement membrane contact (Strange 
et al., 1992; Talhouk et al., 1991). In culture however we did not detect expression 
of stromelysin (a major protease induced during mammary involution: Strange et al., 
1992) during the period of lumen formation when apoptosis was increased. This 
suggests that loss of basement membrane contact, which induces apoptosis, may in 
these circumstances be due to mechanisms other than protease -induced breakdown of 
the basement membrane. Apoptosis was also detected at peak lactation in vivo, at a 
time when proteases were reported not to be expressed (Strange et al., 1992). It is 
therefore possible that apoptotic cells at peak lactation may, by some unknown 
mechanism, lose basement membrane contact by a protease- independent pathway, and 
undergo apoptosis.
IGF-1 is a potent mitogen for mammary tissue (Ruan et al., 1992; Deeks et 
al., 1988) and has an anti-apoptotic effect in other cell types (Rodriguez-Tarduchy et 
al., 1992, Drago et al., 1991; Sell et al., 1995). High concentrations of an IGF 
binding protein have been demonstrated in milk during involution of rat mammary 
gland (Tonner et al., 1995) and this IGFBP has been recently identified as IGFBP 5 
by Northern analysis (M. Travers, personal communication). Western blotting has 
revealed the IGFBP to have an apparent Mr of approximately 30kDa, similar to that 
of IGFBP 5 (D. Flint, personal communication). Tenniswood and colleagues (1995) 
have also recently identified a presently uncharacterised IGFBP, which is elevated 
during mammary involution (M. Tenniswood et al., personal communication). Earlier 
studies by this same group detected elevated RSG 8 in prostate after androgen ablation, 
and demonstrated that RSG 8 codes IGFBP 5 (Guenette et al., 1994). IGFBP 5 binds
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IGF-1 with high affinity and therefore sequesters IGF-1 in the extracellular matrix and 
attenuates the interaction between IGF-1 and the IGF-1 receptor, and induces apoptosis 
(Guenette and Tenniswood, 1995). Therefore in addition to regulation of apoptosis by 
the extracellular matrix, changes mediated through IGF-1 may be important.
Apoptosis has also been reported to occur in whole organ mammary culture 
upon withdrawl of hormones from the culture media (Atwood et al., 1995). This may 
prove to be a suitable model for studying apoptotic changes during involution of the 
gland at the end of lactation. However whole organ in vitro studies have the 
disadvantage that they contain both epithelial and stromal elements and so epithelial cell 
specific effects can not be investigated and often the tissue must be primed with 
hormones prior to removal form the animal, a factor which may influence many 
studies. Levels of apoptosis have been reported to be higher in whole organ cultures 
than in fully functional mammary tissue, suggesting that cell death pathways in organ 
cultures may be under additional pressures not experienced in lactating glands. The 
mammosphere cell culture system ensures that the structural and functional similarity 
with cells in vivo combined with advantages of cell accessability. The demonstration 
of apoptosis in this system (Boudreau et al., 1995) suggests this is a suitable system for 
study of mammary apoptosis. The increase in apoptosis beyond day 8 in this system 
may provide an in vitro model for the study of mammary apoptosis induced during 
involution at the end of lactation. This study has determined the importance of laminin 
in maintainance of cell integrity and the possible regulation of mammary apoptosis by 
an IGFBP, probably IFGBP, 5 in vitro. It is likely that laminin is responsible for cell 
survival in vivo and preliminary experiments suggest IFGFBP 5 may play a role during 
mammary apoptosis in vivo. The effects of manipulating levels of laminin and IGFBP
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5 in vivo, and investigation of the influence of these extracellular signals upon systemic 
and local regulatory mechanisms during mammary apoptosis, will clarify the roles and 
possible interactions of laminin and IGFBP 5 during mammary development and 
function.
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CHAPTER SEVEN 
SUMMARY AND DISCUSSION
Mammary cell number during lactation depends upon the extent of proliferation and 
cell death in the gland. A dynamic balance between the two determines mammary cell 
number and this is a primary determinant of milk yield. Until recently changes in cell 
number were only considered in the context of proliferative changes (Knight and Peaker 
1982a, Knight et al., 1984). The realisation that cell death, by apoptosis, could be a 
regulated process has occurred with the advent of techniques which can monitor the 
extent of DNA fragmentation.
This study has increased knowledge of the physiological role of apoptosis in 
mammary tissue. Perhaps most importantly this work has demonstrated that apoptosis 
is not reserved for gland involution, that it occurs, albeit to a lesser degree throughout 
lactation (Chapter 3). However, apoptosis
occurs to a comparable extent in concurrently-pregnant mice and in non­
pregnant counterparts (Chapter3) and mammary re-development and involution were 
shown to occur simultaneously (Chapter 3). Further, the project has demonstrated that 
mammary apoptosis is controlled both systemically and locally within the tissue 
(Chapters 3, 4 and 5).
The importance of apoptosis throughout a ruminant lactation cycle (Chapter 
5) suggests that manipulation of apoptotic pathways may provide a means of altering 
ruminant cell number during lactation. One of the milking studies in Chapter 5
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commenced at day 3 of lactation, a time which was subsequently found to be associated 
with a high number of apoptotic deaths. The reason for the high level of apoptosis in 
early lactation is unknown. It is possible that a reduction in apoptosis at this time may 
result in an increased cell number throughout lactation. Changes in milking frequency 
during early lactation have been shown to result in altered milk yield (Henderson et al., 
1983, 1985; Knight and Wilde, 1987; Wilde et al., 1989; 1991) due to short term 
differentiative changes (Wilde et al., 1987b, Wilde and Knight 1990). Short term 
alterations in the extent of apoptosis and cell number may be achieved by immediate 
introduction of milking regimes upon establishment of lactation rather than at day 3 of 
lactation, a time by which extensive cell removal possibly could have occurred. 
Although at present it is unclear if at this stage dying cells are epithelial or not.
Previous studies also indicated that longer term alterations in milking 
frequency may be achieved by altering cell number (Wilde et al, 1987b). Decreasing 
the level of apoptosis during declining lactation may prolong epithelial cell life and 
function. Decreased apoptosis during declining lactation may ensure some cells do not 
die at the end of a lactation cycle and instead these cells may be carried over into a 
subsequent lactation cycle to increase milk yield in the next lactation.
This thesis has established that many of the extracellular factors necessary for 
successful lactation are also important regulators of mammary apoptosis. Milk 
accumulates within alveolar spaces when milk synthesis is greater than demand,and 
results in a local stimulation of the apoptotic pathway (Chapter 3). Endocrine signals 
released during suckling maintain lactation (Knight, 1993; Flint et al., 1992) and also 
act as cell survival factors by suppressing entry of cells into apoptosis (Chapter 4). In 
addition, in rodents where prolactin is considered the principal galactopoietic hormone,
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growth hormone has also been demonstrated to exert an influence on mammary 
apoptosis (Chapter 4).
The mammosphere culture system has already been used to provide 
information on the regulation of lactation. The effects of luminal evacuation and filling 
can be investigated by either EGTA treatment or by microinjection techniques which 
provide a means of removing and examining mammosphere contents and of adding 
components to luminal contents and later examining the effect. These techniques will 
enable a finer tuning of mammary epithelial cells than is possible in vivo, and the 
precise effects of addition of FIL, antibodies to FIL on mammopshere structure and 
function could be determined. Similarly the mechanism of action of other agents which 
act locally to induce apoptosis, such as glucocorticoids and progesterone (Feng et al., 
1995) can be determined using the EHS culture system. These components could be 
added alone or in combination and the effects of administration on the amount and 
composition of milk secretion can be determined by Bradford protein determination and 
Western blotting for various milk proteins. The effects of these treatments on cell life 
and death could also be investigated using DNA fragmentation techniques.
Integration between local and endocrine control mechanisms is likely since 
unilateral teat sealing in mice and unilateral cessation of milking in goats results in 
increased apoptosis in treated and in untreated tissue (Chapters 3 and 5). Evidence for 
interaction between local and endocrine control mechanisms has also been obtained 
from study of the feedback inhibitor of lactation (FIL), since FIL can regulate hormone 
receptor number in the mammary gland (Bennett, 1993). Comparision of the extent 
and time course of apoptosis with and without administration of antibody to FIL or 
antibody to FIL receptors during involution induced by bromocriptine and / or anti
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growth hormone treatment may demonstrate the existence of local and endocrine 
interactions. Alternatively, comparision of the extent and time course of apoptosis and 
involution with and without administration of prolactin and / or growth hormone during 
unilateral teat sealing in rodents or during unilateral cesation of milking in ruminants 
may reveal the extent of local and endocrine interactions. Finally evidence for 
apoptosis or involution after administration of antibody to FIL or FIL receptors during 
locally induced apoptosis (teat sealing in rodents mr cessation of milking in ruminants) 
would enable investigation of the overlap of local and endocrine pathways.
Degeneration of mammary epithelium during gland involution coincided with 
an increase in both p53 gene expression and extracellular protease levels (Lefebvre et 
al., 1992; Strange et al., 1992; Talhouk et al., 1992; Guenette et al., 1994)). Indeed, 
apoptotic tissue degeneration is frequently associated with elevation of p53 (Clarke et 
al., 1993; Lowe et al., 1993) and proteases (Sensibar et al., 1990; Leah et al., 1993), 
suggesting a common mechanism for apoptosis in many tissues. The timecourse of 
induction of p53 and protease activity in mammary tissue depended upon the method 
of induction of apoptosis, but in most cases both p53 and protease activity increased 
simultaneously (Chapter 3). The increase in protease activity suggests mammary 
apoptosis is dependent on loss of basement membrane integrity. However nick end 
labelling detected DNA laddering at peak lactation when alveoli were apparently intact 
(Chapter 3). This suggests that there is not always a link between ECM degradation 
and apoptosis and that dissociation from the ECM may be sufficient to cause individual 
cell death. Indeed, in vitro lumen formation (Chapter 6) is consistent with a link 
between ECM contact and cell death, since protease degradation is not imperative to 
the stimulation of apoptosis and that perhaps loss of contact between intact basement
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membrane and the mammary epithelial cells may be sufficient to trigger apoptosis.
To follow up the importance of loss of basement membrane contact and the 
role of proteases in the mammary gland the effect of a range of proteases and protease 
inhibitors could be investigated in vivo throughout pregnancy, lactation and involution. 
This may be achieved by either intra-mammary injection of antibodies to proteases and 
their inhibitors or by intra-mammary implantation of slow release capsules containing 
proteases and inhibitors. Simliar experiments could be performed with antibodies to 
or capsules containing basement membrane components to provide comprehensive 
information on the roles of specific basement membrane components during various 
phases of the lactation cycle. To date a role for laminin has been determined during 
fl casein production (Streuli et al 1993), but as yet the precise roles of collagen, 
vitronectin and fibronectins are undetermined through pregnancy, lactation and 
involution.
Changes in gene expression have, of course,been catalogued in a wide range 
of apoptotic situations (Schneider et al., 1988; Strange et al., 1992) and a common 
pattern of changes in gene expression is emerging (Nunez et al., 1990; Kastan et 
a l., 1991; Yonnish-Rouach et al., 1991; Evanetal., 1992, Fandini et al., 1992; Garcia 
et al., 1992). As part of my study of mammary apoptosis I have mapped the changes 
in key genes implicated in programmed cell death and remodelling of the extracellular 
matrix. Knowledge of the genetic changes will be of central importance in elucidating 
the apoptotic process in mammary tissue. Therefore in continuation of this project the 
effect of genes previously shown to be important during apoptosis could be investigated 
using transgenic studies where a particular gene is selectively over or under expressed 
in mammary tissue. The effect of transgenes on mammary development, lactation and
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involution would determine the gene’s role (if any) in mammary apoptosis. Gene 
interactions could also be identified since omission or enhancement of a gene may alter 
levels of expression of other genes known to be important during mammary apoptosis. 
This type of study would provide valuable information on the influence of genetic 
events during mammary apoptosis.
This transgenic approach to the study of mammary cell turnover is already 
being exploited in several laboratories. The role of p53 would be of particular interest 
during mammary apoptosis since elevation of p53 is one of the earliest genetic 
alterations detected during mouse mammary involution (Strange et al., 1992). 
However mutant p53 transgenic mice display an impaired ability to lactate and the mice 
expressing the highest levels of mutantp53 were unable to nurse their young (Li et al., 
1994). In this respect the role of wild type p53 would be interesting to follow. There 
is increasing evidence that defective apoptotic cell death may also be an early event in 
neoplastic development of the mammary gland, and p53 is reported to be mutated in 
a high proportion of breast tumours (Levine et al., 1991). The importance of 
hyperplastic pre-cancerous lesions in human breast cancer has long been recognised 
(Ewing, 1914). They represent the earliest identifable intermediates in breast tumour 
development (Page and Dupont, 1990) and their subsequent progression to tumours has 
been clearly documented (Medina, 1988). If hyperplastic nodules are the product of 
impaired apoptosis this suggests that the cycle of mammary development and involution 
during pregnancy, lactation and weaning may confer protection against a malfunction 
of apoptosis. This may explain why null parity is a positive risk factor for 
premenopausal mammary cancer. Investigation of this phenomenon warrents further 
study.
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Studies using transgenic animals will also enable the importance of bcl-2 
family genes to be established during mammary apoptosis. This work could ascertain 
the importance of these genes during mammary development and involution, and 
establish which members of this gene family are playing a role in programmed cell 
death not only in the mammary gland but in other tissues, as at present the roles of the 
different bcl-2 family genes are unclear (Boise et al., 1993; Gonzalez-Garcia et al., 
1994; Oltvai et al., 1993). Animals expressing different bcl-2 transgenes may show 
that one family member can substitute for others, or may determine that each member 
has a clearly defined role in the mammary gland. The precise interactions of the bcl-2 
family with each other (Oltvai et al., 1993; Takayama et al., 1995; Yang et al., 1995) 
and with other genes which are involved in regulating mammary apoptosis, such as 
proteases and p53, (Wang et al., 1993; Chiou et al., 1994) will increase understanding 
of the mechanisms underlying the regulation of mammary cell survival and apoptosis.
The information contained in this thesis will, it is hoped, stimulate future 
studies on intracellular pathways and nuclear events that are important during mammary 
apoptosis, so that the mechanisms dictating cell survival and apoptosis can be 
understood. These studies may eventually enable the controlled manipulation of 
apoptotic pathways in mammary tissue and specific treatment of disease states where 
apoptotic pathways are malfunctioning.
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